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Psychosis encompasses a constellation of symptoms that have far-reaching social, 
physical and functional consequences for sufferers. One of the key clinical concerns 
in the management of psychotic illnesses is the risk of suicide, which is greatest in the 
early stages of psychosis. Hopelessness is consistently associated with risk for suicide 
but as a concept it is not well defined and is not specific enough to be of use in 
prediction of suicide. Future-directed thinking, particularly regarding positive future 
events, constitutes an aspect of hopelessness that is closely associated with risk for 
suicide. This study employed the Future Thinking Task to investigate whether future-
directed thinking in first episode psychosis is significantly different from that of 
matched controls in performance or content, and to clarify the nature of its association 
with suicide risk in this patient group. In addition, the association of future-directed 
thinking with the negative symptoms of psychosis was investigated. 
 
The results showed that individuals with psychosis were impaired in future-directed 
thinking globally, particularly with respect to the coming year. Specific deficits were 
shown in the domains of relations with other people and personal development and 
understanding. Associations were shown between future-directed thinking and 
suicide, and reduced positive future-directed thinking was shown to be strongly 
associated with increased severity of negative symptoms. The results suggest avenues 
for novel interventions to improve hopelessness, suicide risk and the severity of 
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Research into the nature of hopelessness suggests that it is characterised more by 
difficulties in anticipating positive events in the future than by excessive anticipation 
of negative events in the future. This study aimed to investigate the future-directed 
thinking of individuals with first episode psychosis in comparison with that of 
matched controls, and its relationship to both suicide risk and the negative symptoms 
of psychosis. This introduction will begin by defining and describing psychosis and 
the risks that the illness can entail, including increased risk of suicide and self-harm. 
The chapter goes on to consider risk factors for suicide in the general population and 
in individuals with first episode psychosis. Hopelessness as a risk factor for suicide is 
considered in detail, and the existing literature on the use of the well-established 
Future Thinking Task to investigate this is reviewed. Recent research on future-
directed thinking in individuals with psychosis will be examined, and a case will be 
made for the use of the Future Thinking Task to investigate future-directed thinking, 
hopelessness and suicide risk in this population. The potential link between future-
directed thinking and the negative symptoms of psychosis will also be considered. 
 
1.2 Psychosis and its consequences 
1.2.1 Introduction to psychosis 
The term psychosis is used to describe a collection of psychiatric symptoms arising as 




secondary pathology, such as certain types of bacterial infection (Cardinal & 
Bullmore, 2011). Its definition has changed over time from its origin the 19th Century, 
in the early  part  of  which  it  was  synonymous  with  the  nonspecific  term  “insanity”  
(Berrios, 1987), to more recent narrow definitions that describe psychosis as the 
presence of delusions or hallucinations in the absence of insight into their pathological 
origins. More broadly, the definition includes insight, and in some classification 
systems it has been expanded to include other symptoms such as disorganised speech 
and catatonic symptoms (American Psychiatric Association, 2000) and distortions of 
thinking and perception (World Health Organization, 1992). 
 
In the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition Revised, 
DSM-IV-TR; American Psychiatric Association, 2000), the term psychotic refers to 
the presence of certain symptoms, the combination and relative prominence of which 
define the individual psychotic disorder. These symptoms include positive symptoms 
such as delusions, hallucinations, disorganised speech, grossly disorganised or 
catatonic behaviour, and negative symptoms such as apathy, blunted emotions and 
social withdrawal. The nine main forms of psychotic disorder described in DSM-IV-
TR are schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional 
disorder, brief psychotic disorder, shared psychotic disorder, psychotic disorder due to 
a general medical condition, substance-induced psychotic disorder, and psychotic 
disorder not otherwise specified (American Psychiatric Association, 2000). These 
vary in severity and aetiology, from durations of less than one month without 
deterioration in functioning (brief psychotic disorder) to durations of at least six 
months with concurrent mood disturbance (schizoaffective disorder). The most 




the evidence presented in this chapter refers. Whilst it must be acknowledged that 
schizophrenia does not provide a perfect model of all psychotic disorders as these are 
diverse and vary in origin, the criteria of all psychotic disorders described in DSM-
IV-TR use the symptoms of schizophrenia as a reference point. Therefore it can be 
argued that schizophrenia provides an adequate model of the constellation of 
symptoms that comprise psychosis. 
 
The age of onset of psychotic disorder is typically in the late teens to early twenties in 
males, and around five years later in females (DeLisi, 1992). However, psychosis can 
also occur in childhood (early onset psychosis), and in adults of any age. The first 
experience of a psychotic episode in an individual is generally known as the first 
episode, and this term is applied to both psychosis generally and schizophrenia 
specifically. In the last 20 years the importance of tailored and intensive intervention 
in the first 2-5 years of psychosis  has been emphasised in achieving good outcomes 
(Birchwood, Todd, & Jackson, 1998; Nordentoft, Rasmussen, Melau, Hjorthoj, & 
Thorup, 2014). This has led to the widespread introduction of specialised early 
intervention services for those in the first 2-5 years of illness. These services apply 
specialised clinical knowledge to the treatment of early psychosis, including assertive 
interventions, appropriate low doses of antipsychotic medication, family 
interventions, and support for substance use (International Early Psychosis 
Association Writing Group, 2005). In comparison with standard community mental 
health care such services have been shown not only to improve outcomes, such as 
reducing the number of days that patients are hospitalised, increasing the percentage 




Chen et al., 2011; Nordentoft et al., 2014) but also to be economical (Hastrup et al., 
2013; Park, McCrone, & Knapp, 2014). 
 
The lifetime prevalence of all psychotic disorders combined has been estimated at 
3.0-3.5%, and is broken down by diagnosis as follows: schizophrenia = 0.9%, 
schizoaffective disorder = 0.3%, delusional disorder = 0.2%, and schizophreniform 
disorder = 0.1%. Lifetime prevalence for substance-induced psychotic disorders have 
been estimated at 0.4%, and for psychotic disorder due to a medical illness = 0.2% 
(American Psychiatric Association, 2013; Perala et al., 2007). The prevalence of 
psychotic disorder in the UK population in 2006 was estimated at 0.4% (Bebbington 
et al., 2009). Incidence has been estimated variously at around 5-20 cases per year per 
100,000 population (Kirkbride et al., 2012; Kirkbride et al., 2006), and has been 
shown to be consistent across countries and cultures by a World Health Organisation 
study across ten countries (Jablensky et al., 1992). The combined direct and indirect 
costs of schizophrenia were estimated at around £6.7 billion for 2004-5, with direct 
healthcare costs accounting for around £2 billion of this total (Mangalore & Knapp, 
2007): this amounts to just under 3% of total National Health Service expenditure in 
that period (Department of Health, 2006). 
 
The presence of psychosis can have serious consequences for the lives of individual 
sufferers. Positive symptoms can be very distressing and their impact on relationships 
and functioning severe. For example, the experience of auditory hallucinations is 
distracting and often highly distressing due to the frequently critical nature of the 
voices heard. Negative symptoms can also impact on functioning, leaving sufferers 




symptoms have also been found to predict functional outcome, with more severe 
negative symptoms at baseline predicting worse functional outcome up to 10 years 
later (Hassan & Taha, 2011; Milev, Ho, Arndt, & Andreasen, 2005; Ventura, 
Hellemann, Thames, Koellner, & Nuechterlein, 2009; C. White et al., 2009). The 
social implications of psychosis can be far-reaching, and impact on areas such as 
work, relationships, family and education. This is made doubly problematic by the 
typical age of onset: as noted above psychosis tends to develop in the early twenties, a 
time when the individual is beginning to establish themselves and gain independence 
in these areas. Disruption to these key processes is likely to have serious implications 
for the future functioning of the individual. Moreover, symptoms such as paranoia and 
delusions can impact on personal relationships to such a degree that they can lead to 
the breakdown of the very support systems that would aid recovery, such as 
relationships with friends and family (Taylor, 1987) and social networks (Allison, 
Harrop, & Ellett, 2013; Macdonald, Hayes, & Baglioni, 2000). Indirect effects of the 
disease such as lack of self-confidence and fear of rejection can make it difficult to 
repair these relationships (Killaspy et al., 2014). 
 
1.2.2 Physical health risks of psychosis 
Psychosis is also associated with serious risks to physical health. Rates of respiratory, 
cardiovascular and metabolic disease are all elevated in individuals with 
schizophrenia (Glassman, 2005; Henderson, 2005; Robson & Gray, 2007), as are rates 
of HIV and hepatitis C (Cournos, McKinnon, & Sullivan, 2005; Leucht, Burkard, 
Henderson, Maj, & Sartorius, 2007). It has been suggested that comorbid psychiatric 
or medical conditions are present in at least 50% of people with schizophrenia (Green, 




with psychosis is as much as two-and-a-half times that in the general population due 
to an increased death rate from both natural and unnatural causes (Brown, 1997; Saha, 
Chant, & McGrath, 2007). In 1997, a meta-analysis of 18 different studies including 
data from the previous four decades investigated the comparative risk of death from a 
variety of causes in individuals with schizophrenia and the general population 
(Brown, 1997). Elevated standardized mortality rates1 (SMRs) were demonstrated for 
a variety of causes including cardiovascular disease, digestive disease and respiratory 
disease. For all causes combined, the aggregate SMR was 1.5, indicating that people 
with schizophrenia were one-and-a-half times more likely to die from any of the listed 
causes than individuals in the general population. The highest SMR, 8.4, was for 
suicide, indicating that suicide was the single biggest cause of death in schizophrenia. 
This result replicated that of a meta-analysis focusing solely on suicide as a cause of 
death in mental illness, which reported an SMR of 8.5 (Harris & Barraclough, 1997).  
 
These results were further supported by a 2007 meta-analysis of 37 different studies 
investigating cause of death in schizophrenia over the previous three decades (Saha et 
al., 2007). Elevated SMRs in schizophrenia compared with the general population 
were demonstrated across a range of natural and unnatural causes. The overall 
aggregate SMR was 2.5, an increase on the figure reported in the Brown study, and 
the aggregate SMR for suicide was 12.9, three times that for any other single cause. 
The results of this study highlight a trend towards increased mortality rates for all 
                                                 
1 Standardized mortality rate is the ratio of observed deaths in a population to the number of 
deaths that would be expected in a reference population. For example, an SMR of 2 would 




causes and for suicide in particular, in comparison with the studies by Brown and 
Harris and Barraclough published just a decade earlier. This increase was found to be 
relative to the general population, in which the suicide rate had fallen, and did not 
reflect an increase in case fatality rates in schizophrenia (Saha et al., 2007). 
Nonetheless, this evidence suggests that suicide is a significant concern in the 
psychotic disorders, and it is with this that the current study is chiefly concerned. 
 
1.3 Suicide and self-harm in psychosis 
1.3.1 Definition of suicide and related acts 
Suicidal and self-harming behaviours have many forms and names that range in 
severity, including suicide completion (when a suicide attempt results in death), 
suicide attempt, non-fatal self-harm with and without suicidal intent, suicide planning, 
and suicidal ideation. The intent to die behind self-harming behaviours is challenging 
to determine, and therefore the boundaries between labels such as suicide attempt and 
self-harm without suicidal intent can become blurred. The Beck Suicide Intent Scale 
was devised as a measure of suicidal intent to be administered after an attempt (Beck, 
Schuyler, & Herman, 1974), but during its development it was acknowledged that it is 
susceptible to threats to validity such as inaccurate or inadequate recall, 
uncooperativeness, and dramatization (Beck, Schuyler, et al., 1974). Further factors 
undermining the accurate measurement of suicidal intent are the perceived social 
desirability of certain responses, impulsivity associated with the attempt, ambivalence 
to suicide and fluctuating intent, and secondary gain of feigning intent, all of which 
may  influence  individuals’  responses  to  such  measures  (Freedenthal, 2007). Evidently 




many cases this has led researchers to avoid the issue altogether, choosing instead to 
treat all forms of self-harm as one entity unless specifically able to identify those with 
high intent (MacLeod, 2013). In the account that follows I will follow the convention 
of referring to all self-harming behaviours that do not result in death collectively as 
deliberate self-harm (DSH). 
 
1.3.2 Prevalence of suicide and DSH in psychosis 
As discussed above, risk of suicide is one of the most significant clinical concerns in 
the management of psychosis. The occurrence of suicide in schizophrenia was 
observed as  early  as  1919,  in  Emil  Kraepelin’s  classic  work  Dementia Praecox and 
Paraphrenia (Kraepelin, 1919). Annual rates of death by suicide in individuals with 
schizophrenia have been estimated at between 0.4 and 0.8% (Alphs et al., 2004), 
whilst rates in the general population of the UK are approximately 0.02% per year 
(Office for National Statistics, 2012). Early estimates of lifetime risk of death by 
suicide in the psychoses were around 10% (Miles, 1977), though recent estimates are 
more conservative, at 4-6% (Hor & Taylor, 2010; Inskip, Harris, & Barraclough, 
1998; Palmer, Pankratz, & Bostwick, 2005). Nevertheless, this remains a significant 
elevation over lifetime risk in the general population, which has been estimated at 
0.5% (Bostwick & Pankratz, 2000), and as noted above, is reportedly as much as 12.9 
times higher in schizophrenia than in the general population (Challis, Nielssen, Harris, 
& Large, 2013). Moreover, in those who have already made a suicide attempt, 
psychosis is associated with higher numbers of repeat attempts when compared with 
individuals without psychosis (Warman, Forman, Henriques, Brown, & Beck, 2004). 
Prevalence of DSH is also high in individuals experiencing psychosis, with some 




DSH at some point in their lives (Morgan et al., 2012; Mork et al., 2012). By contrast, 
the highest estimate of the lifetime prevalence of DSH in the general population is just 
under 6% (Welch, 2001), with most estimates ranging from 1-4% (MacLeod, 2013). 
 
Risk of suicide has been shown to be highest in the early stages of psychosis, soon 
after diagnosis (Carlborg, Winnerback, Jonsson, Jokinen, & Nordstrom, 2010; Palmer 
et al., 2005; Pompili et al., 2011). Dutta et al. (2010) performed a long-term follow-up 
study of 2,723 individuals with first episode psychosis who presented to secondary 
care services across the UK. In the follow-up period of up to 20 years, 15% of the 
total suicides occurred within the first year. SMR was highest in the first year (11.1), 
and dropped incrementally with time. Studies have shown that risk is especially high 
in the post-psychotic phase of recovery, soon after discharge from hospital (Hunt et 
al., 2009; Rossau & Mortensen, 1997). Reasons for this are hypothesised to be 
connected with the realisation of loss of role and function, the frustrations associated 
with the recovery process, and difficulties with everyday activities (Power & 
McGowan, 2011). However, suicide is associated with all stages of the early illness, 
including acute psychosis–around 11% of suicides have been found to be directly 
associated with hallucinations during the active phase of psychosis (Nordentoft et al., 
2002)–and the early stages of relapse (Power & McGowan, 2011). 
 
Few studies have investigated the change in risk for DSH over the course of psychotic 
illness, as the majority of research has focused on the risk factors for completed, 
rather than attempted suicide. However, in one study Verdoux et al. (2001) report a 
similar pattern to that observed in suicide completion, showing that of the acts of 




year and only 20% in the second. In another study of 94 individuals with early 
psychosis (Fedyszyn, Robinson, Matyas, Harris, & Paxton, 2010) suicide risk, based 
on suicidal ideation and attempts, was assessed over the course of 2 years using the 
suicidality item of the Brief Psychiatric Rating Scale. Suicide risk was found to be 
highest in the first months of treatment, declining in the six months thereafter. 
 
Risk of DSH is not only elevated in the early stages after first contact with services: 
high rates have also been identified retrospectively in the period before first contact. 
Rates of DSH between 7% and 28% have been reported in adults (J. Addington, 
Williams, Young, & Addington, 2004; Andriopoulos, Ellul, Skokou, & Beratis, 2011; 
Bakst, Rabinowitz, & Bromet, 2010; Upthegrove et al., 2010) and up to 32% in 
adolescents (Falcone et al., 2010) prior to first admission or contact with services. A 
meta-analysis of studies of acts of DSH in early psychosis (Challis et al., 2013) found 
that almost 20% of people presenting with first episode psychosis reported a history 
of self-harm, and nearly 10% reported having self-harmed between the onset of 
symptoms and first presentation to services. This figure supports an earlier finding by 
Harvey et al. (2008) that 11% of individuals presenting to services for the first time 
reported self-harming during the period of untreated psychosis. It is also important to 
remember that, whilst it is challenging to determine how many people with psychotic 
illness complete an act of suicide before presenting to services, it is likely that this 
figure is not negligible. Suicide risk is high even in those identified as at risk for 
future psychosis: in one study (Hutton, Bowe, Parker, & Ford, 2011) suicide risk was 
investigated in a group of individuals in a treatment programme for those at ultrahigh 
risk (UHR) of psychosis. Of those included in the study, 59% reported suicidal 




with 90% of a UHR sample reporting suicidal ideation during a 6 month period, and 
25% attempting suicide at least once (Adlard, 1997, as cited in Hutton et al., 2011). 
These studies highlight the high risk of suicide and DSH in the early stages of 
psychotic disorders, and the importance of understanding the factors associated with 
these for clinical practice in early intervention settings. In order gain a better 
understanding of suicide risk in psychosis, it is important first to consider risk for 
suicide in the general population. 
 
1.3.3 Risk factors for suicide 
Risk factors for suicide can be split into proximal and distal factors (Hawton & van 
Heeringen, 2009). Distal factors are described as traits of the individual such as 
gender, genetics, personality, early traumatic life events and neurobiology. They are 
usually historical factors, and tend not to be amenable to change or outside influence. 
Proximal factors relate to current state, such as psychiatric or physical disorder, recent 
crises, and access to means to complete suicide. They are usually current or recent, 
and can be somewhat amenable to change or outside influence, though not always. 
The most common risk factor for suicide is widely acknowledged to be a history of 
DSH (Cavanagh, Carson, Sharpe, & Lawrie, 2003). Studies have shown that 54% of 
people who attempt suicide have a history of DSH (Kerkhof, 2000), and 
approximately 1% then go on to complete suicide within one year (Sakinofsky, 2000). 
In a 2002 meta-analysis of repeat DSH and completed suicide following an act of 
DSH, repetition rates were estimated at 15-16% in the first year, and one-year median 
completion rate following DSH was 1.8% (Owens, Horrocks, & House, 2002). This 
figure is somewhat higher than reported by Sakinofsky, although the quality of the 





Numerous other factors have been associated with suicide. Psychiatric disorder, 
especially depression, has been found to be present in up to 90% of those who 
complete suicide (Cavanagh et al., 2003), and it has been argued that this figure, 
though high, is an underestimate (Ernst et al., 2004; Flavio et al., 2013; Zhang & Li, 
2013). Other factors associated with suicide are physical ill-health, male gender 
(though the opposite is true in DSH), older age, living alone, recent major life events, 
childhood maltreatment, alcohol misuse, and increased hopelessness (Hawton & van 
Heeringen, 2009; Nock et al., 2008). Risk factors for suicide in psychosis are related 
to those in the general population in one of three ways: (1) the same risk factors apply 
as in the general population, (2) the factors are the same, but risk is conferred in the 
opposite direction to that observed in the general population, or (3) risk factors are 
specific to individuals with psychosis. 
 
Risk factors that are the same in psychosis and the general population are much the 
same in both the early stages of psychosis and more established cases. They are male 
gender, living alone, increased severity of depressive symptoms, higher impulsivity 
and aggression, having a history of previous suicide attempts, substance misuse, and 
increased hopelessness (Balhara & Verma, 2012; Caldwell & Gottesman, 1990; Drake 
& Cotton, 1986; Hawton, Sutton, Haw, Sinclair, & Deeks, 2005; Meltzer, 2002; Reid, 
1998). By contrast, some factors that increase risk for suicide in the general 
population confer risk in the opposite direction to that expected in individuals with 
psychosis. For example, older age increases risk in the general population whereas 
younger age increases risk in psychosis (Bakst et al., 2010; Ran, Chan, Xiang, & Wu, 




population, but confers risk in psychosis (Caldwell & Gottesman, 1990; Carlborg et 
al., 2010).  Yet other risk factors for suicide in psychosis are unique to the disorder. 
These include increased thought disorder (Bakst et al., 2010), increased insight into 
illness (Barrett, Sundet, Faerden, Agartz, et al., 2010; Lopez-Morinigo, Ramos-Rios, 
David, & Dutta, 2012; Robinson et al., 2009), longer duration of untreated illness 
(Altamura, Bassetti, Bignotti, Pioli, & Mundo, 2003), and negative beliefs about 
psychosis (Barrett, Sundet, Faerden, Agartz, et al., 2010). Research conducted into 
suicide risk in the very early stages of psychosis prior to first presentation to services 
has found that, in addition to the above-mentioned risk factors, younger age at onset 
and longer duration of untreated psychosis are associated with increased risk of DSH 
and suicidal ideation before first presentation (Altamura et al., 2003; Barrett, Sundet, 
Faerden, Nesvag, et al., 2010; Clarke et al., 2006; Harvey et al., 2008). 
 
1.4 Hopelessness as a risk factor for suicide 
1.4.1 Overview of hopelessness 
Hopelessness is a risk factor shared by almost all individuals who attempt or complete 
suicide, regardless of psychiatric diagnosis (if present). It has  been  described  as  “a  
system of cognitive schemas whose common denomination is negative expectations 
about  the  future”  (Beck, Weissman, Lester, & Trexler, 1974, p. 864). This concept 
was  later  captured  within  Aaron  Beck’s  negative  cognitive  triad  model of depression 
(Beck, Rush, Shaw, & Emery, 1979), in which depression is described as a negative 
cognitive style applied to each of three areas: the self, the world, and the future. In 
this model, hopelessness is equivalent to having negative views of the future (Hanna 




the most commonly used and best-researched measure is the self-report Beck 
Hopelessness Scale (BHS; Beck, Weissman, et al., 1974; Glanz, Haas, & Sweeney, 
1995). This is a 20-item measure which requires participants to respond true or false 
to positive and  negative  statements  such  as  “I look forward to the future with hope 
and  optimism”  and  “My  future  seems  dark  to  me”. The BHS has good reliability and 
validity (Beck, Weissman, et al., 1974) and has been shown to correlate well with 
clinical ratings of hopelessness (Beck, Brown, & Steer, 1989).  
 
Many investigators have shown that self- and clinician-rated hopelessness are strong 
predictors of later suicide (Beck, Brown, Berchick, Stewart, & Steer, 1990; Beck et 
al., 1989). Self-reported hopelessness has been shown to predict suicidal ideation, 
DSH and suicide completion in numerous studies (Beck, Steer, Kovacs, & Garrison, 
1985; McMillan, Gilbody, Beresford, & Neilly, 2007; Petrie, Chamberlain, & Clarke, 
1988; Salter & Platt, 1990; Zhang & Li, 2013). Furthermore, self-reported 
hopelessness has been shown to mediate the relationship between depression and 
suicide: a stronger relationship is found between measures of hopelessness and 
suicide behaviour than between measures of depression and suicide behaviour (Beck, 
Kovacs, & Weissman, 1975; Beck et al., 1985; Minkoff, Bergman, Beck, & Beck, 
1973). This indicates that of the three elements of the negative cognitive triad model 
of depression, it is negative views in relation to the future that confer the greatest risk 
for suicide. 
 
1.4.2 Hopelessness and risk for suicide in psychosis 
Where measured, hopelessness is consistently linked with risk for suicide in 




motivation of the act, which can be either depressive or psychotic (Acosta et al., 
2006). Hopelessness has also been found to mediate the relationship between suicide 
and depression in psychosis (Drake & Cotton, 1986), replicating the effect seen in the 
general population and showing that in psychosis too, a stronger relationship is found 
between measures of hopelessness and suicide behaviour than between measures of 
depression and suicide behaviour. 
 
The association between hopelessness and suicide risk in psychosis has been borne 
out by several meta-analytic and systematic reviews (Balhara & Verma, 2012; 
Hawton et al., 2005; Large, Smith, Sharma, Nielssen, & Singh, 2011), confirming that 
this is a consistent effect in psychosis as well as other populations. However, it is of 
note that these meta-analyses have predominantly included studies of individuals with 
chronic psychosis. Given that suicide risk is elevated in the early part of the illness, 
we might ask whether this elevation is associated with hopelessness, or whether it is a 
result of another aspect of early psychosis, for example the experience of being 
diagnosed. One qualitative study by Pitt and colleagues (2009) identified both positive 
and  negative  aspects  to  the  impact  of  diagnosis,  with  “prognosis  of  doom”  and  “social  
stigma”  as  key  negative subthemes in the final model, whilst another study of 
reactions to a diagnosis to bipolar disorder (Proudfoot et al., 2009) identified feelings 
that bad times are inevitable in the future. Three studies that may begin to clarify the 
relationship between hopelessness and suicide and DSH are notable by the fact that 
they are prospective studies specifically in early psychosis. All three use long-term 





The OPUS trial (Nordentoft et al., 2002) is a large 5-year follow-up and treatment 
trial of 578 inpatients and outpatients in their first episode of a schizophrenia 
spectrum disorder. During the first year of treatment 11% of the 386 participants 
followed up attempted suicide (of which 7% were successful) and a significant 
association was revealed between hopelessness and suicide attempt (Madsen & 
Nordentoft, 2012). This association disappeared when the occurrence of previous 
DSH was controlled for, suggesting that in those without previous DSH hopelessness 
was not associated with suicide attempt. However, it should be noted that 
hopelessness was measured using just one item from the Schedule for Clinical 
Assessment in Neuropsychiatry and therefore may not convey the entire picture of its 
association with DSH. In a 7-year follow-up study of 282 first-episode outpatients 
(Robinson et al., 2010) 22% attempted suicide and 4% died as a result. Hopelessness 
at baseline was a significant predictor of DSH in the follow-up period. Moreover, the 
majority of DSH occurred in the first 5 years of the follow-up period (94%), and the 
mean time to completion of suicide was 4 years. These findings are consistent with 
the presence of an association between hopelessness and DSH in the early years of 
psychotic illness. As in the OPUS trial, hopelessness was measured using a subsection 
of a clinical interview. Finally, a prospective study of 414 individuals with first 
episode psychosis showed that hopelessness scores at each measured time point 
(baseline, 6 months, 24 months, 48 months and 120 months) predicted suicide 
attempts at the next time point, over and above the contribution of previous DSH to 
the model (Klonsky, Kotov, Bakst, Rabinowitz, & Bromet, 2012). These results 
contradict those of the OPUS study described above, possibly because, unusually for a 
long-term follow-up study, these authors used the full BHS to measure hopelessness, 





The aforementioned studies show that hopelessness is a key predictor of later suicide 
in first episode psychosis, and is thus a potential target for the clinical management of 
suicide risk in this vulnerable population. Hopelessness is one of very few factors that 
is not only consistently associated with increased risk for suicide, but is also 
potentially amenable to change. Many other factors strongly associated with increased 
risk, such as gender, life events, and history of DSH, cannot be modified as they are 
distal or historical risk factors. Hopelessness, as a proximal risk factor, offers a rare 
opportunity to affect the risk of suicide through cognitively-oriented treatments such 
as “LifeSPAN  therapy” (Power et al., 2003), and integrated treatments including 
assertive community treatment and family interventions  (Nordentoft et al., 2002) 
which have been shown to reduce hopelessness in suicidal patients with early 
psychosis. Conversely, evidence is contradictory for treatments aimed at reducing 
suicidality as a whole in individuals with psychosis (Donker et al., 2013) and in all 
individuals (Hawton et al., 1999). However, whilst its association with suicide is 
clear, a key question that remains is the clinical utility of hopelessness as a predictor 
of suicide in practice. The following section considers the difficulties inherent in this 
strategy. 
 
1.4.3 Challenges of global hopelessness ratings 
Like all factors that have been found to be associated with increased risk of suicide, 
hopelessness cannot predict which individuals will attempt or complete suicide, it can 
only identify groups that are at increased risk. Studies attempting to predict future 
suicide tend to be able to identify cases well (they are sensitive) but they tend also to 




completed suicide correctly predicted by a given model, many more are identified 
incorrectly as being at risk who would never go on to attempt suicide (MacLeod, 
2013). For example, the BHS has high sensitivity and low specificity: although over 
80% of people who will go on to complete suicide may be identified by a minimum 
BHS score of 9, these will comprise only 42% of the whole population that this cut-
off identifies as being at risk (McMillan et al., 2007). This is problematic for 
treatment, which may be costly and potentially unethical to administer to those who 
would not go on to attempt or complete suicide. There is a need to increase specificity 
and identify which elements of hopelessness confer particular risk for suicide. 
 
Many attempts have been made to deconstruct the concept of hopelessness into 
hypothesised individual components for this purpose. To date, the principal method 
for identifying individual components of hopelessness has been to apply factor 
analysis to data collected using the BHS. In their original description of the scale, 
Beck and colleagues described that the BHS had a three factor structure: an affective 
component,  labelled  “Feelings  About  The  Future”,  a  motivational component, 
labelled  “Loss  Of  Motivation”,  and  a  cognitive  component,  labelled  “Future  
Expectations”  (Beck, Weissman, et al., 1974). Since this time, investigators have 
continued to use factor analysis to examine dimensionality in the BHS. Structures 
consisting of one (Aish, Wasserman, & Renberg, 2001; Hanna et al., 2011), two 
(Nissim et al., 2010; Pompili, Tatarelli, Rogers, & Lester, 2007; Tanaka, Sakamoto, 
Ono, Fujihara, & Kitamura, 1998), and three (Dyce, 1996; Hill, Gallagher, 
Thompson, & Ishida, 1988; Steer, Kumar, & Beck, 1993) factors have all been 
described, highlighting the complexity and ambiguity surrounding self-reported 




factors identified do not replicate those in the original 1974 analysis. Instead factors 
were identified that  they  labelled  “Rejection  Of  The  Possibility  Of  A  Hopeful  
Future”, “Acceptance Of The Inevitability Of A Hopeless Future”, and “Resignation 
To  The  Futility  Of  Changing  The  Future”  (Steer et al., 1993, p. 559). Thus it is clear 
that self-reported hopelessness, even as measured by a well-researched and well-
validated tool, is a difficult concept to describe and define. 
(MacLeod, Rose, & Williams, 1993) 
In an alternative, theoretically-driven (rather than data-driven) attempt to deconstruct 
hopelessness, investigators have argued that it can be conceptualised in two distinct 
ways: an inability to imagine good things in the future and an increased tendency to 
imagine bad things in the future (Abramson, Alloy, & Metalsky, 1989, as cited in 
MacLeod, Rose, & Williams, 1993). Previously it has not been clear whether these 
two possibilities are functionally distinct (MacLeod et al., 1993), but work 
distinguishing these two alternatives, described below, has provided valuable 
information in the search for the specific components of hopelessness that are 
associated with suicide. 
  
1.4.4 The Future Thinking Task 
The Future Thinking Task (FTT; MacLeod et al., 1993) was developed especially for 
the purpose of distinguishing inability to imagine good things in the future from 
increased tendency to imagine bad things in the future, as well as to separate thoughts 
about near through to distant time periods in the future. The FTT is a modified verbal 
fluency task in which participants are asked to name events in the next week, year and 
five to ten years that they are looking forward to and not looking forward to (positive 




different time period and valence, thus there are six trials, lasting one minute each. 
The number of events generated in the positive condition is used as a measure of 
positive future thinking (PFT), and the number of events generated in the negative 
condition is used as a measure of negative future thinking (NFT). 
 
Hopelessness has been shown to correlate negatively with PFT, meaning that as 
positive future thinking increases, hopelessness decreases. However, no association is 
shown between hopelessness and NFT (Hunter & O'Connor, 2003; MacLeod, 
Pankhania, Lee, & Mitchell, 1997; O'Connor, O'Connor, O'Connor, Smallwood, & 
Miles, 2004). In another study of individuals hospitalised for a recent episode of DSH 
(MacLeod et al., 2005) a stronger correlation was demonstrated between hopelessness 
and decreased PFT than between hopelessness and increased NFT. These studies 
provide evidence that a difficulty in imagining good things in the future is 
functionally distinct from the tendency to imagine bad things in the future, and 
moreover, may be a more specific measure of hopelessness than the BHS.  
 
The FTT, and specifically PFT, has been shown to have construct validity as a 
measure of hopelessness though the demonstration of its association with suicidality. 
In several studies, patients hospitalised for recent suicide attempts have been 
compared with hospital and community controls on measures of hopelessness and 
using the FTT. The earliest study to use the FTT (MacLeod et al., 1993) studied 
patients admitted with acute self-poisoning, and found a significant reduction in PFT 
in the DSH group compared with hospital and community control groups. This result 
has since been replicated in individuals admitted as a result of any act of DSH, 




1998), and in older adults (Conaghan & Davidson, 2002). Importantly, no increase in 
negative future thinking was observed in the DSH group in any of these studies. This 
pattern has been shown to persist when depression is controlled for (MacLeod, 
Pankhania, et al., 1997; MacLeod et al., 2005), and it is not solely attributable to 
anhedonic responses (reduced pleasure ratings) to potential positive things in the 
future (MacLeod & Salaminiou, 2001), which are common in depression. Not only 
has PFT been associated with hopelessness in individuals with who have recently 
attempted suicide, it has also been shown to predict risk for suicide. O'Connor, Fraser, 
Whyte, Machale, and Masterton (2008) found that in people with repeated acts of 
DSH reduced PFT was not only associated with levels of suicidal ideation 2.5 months 
after discharge, but was also superior to global hopelessness ratings in predicting this. 
 
In summary, this evidence suggests that reduced PFT is a component of global 
hopelessness that is crucial in understanding and potentially predicting risk for 
suicide. Reduced PFT is associated with higher hopelessness and increased  risk for 
suicide, and is more closely related to suicidal ideation than global self-reported 
hopelessness, suggesting that it may demonstrate greater specificity in predicting 
future DSH than the BHS. As well as providing a measure of hopelessness that is 
arguably more specific than the BHS, a further advantage of the FTT is that it is an 
objective rather than self-report measure and is therefore less susceptible to the 
potential influence of social desirability (Ivanoff & Jang, 1991; Linehan & Nielsen, 
1981). Moreover, it is quickly administered and easily understood by participants 
(MacLeod et al., 1993). The FTT may therefore be a potentially useful and clinically 




considers the extent to which future-directed thinking has been studied in psychosis to 
date. 
 
1.4.5 Future-directed thinking in psychosis 
Very few studies have investigated the ability of individuals with psychosis to think 
about the future, and no published studies to date have employed the FTT in a first 
episode psychosis sample. However, five studies may be relevant to the concept of 
future-directed thinking. First, Eack and Keshavan (2008) studied ability to anticipate 
the  consequences  of  one’s  actions in a sample of 58 individuals with schizophrenia. 
The participants showed a reduced level of foresight, which predicted functional 
disability at 1-year follow-up. However, this study did not use a control group, so the 
extent to which foresight was impaired in comparison with the general population was 
not clear. 
 
Four further studies have explored the ability of individuals with schizophrenia to 
generate and elaborate future events in response to given cues. In one study 
(D'Argembeau, Raffard, & Van der Linden, 2008), participants were asked to 
generate detail about future events that might reasonably happen to them, in response 
to cues about general everyday situations or feelings. One response per cue was 
required and respondents were given one minute for each trial. Responses were coded 
for specificity, that is, the extent to which they were associated with a particular time 
(less than a day) and place. The results showed that patients were impaired in 
generating specific events in comparison with controls. Another study (Raffard, 
D'Argembeau, Bayard, Boulenger, & Van der Linden, 2010) required that participants 




generate three events that might plausibly happen to them in the future. Each 
description was rated on a number of dimensions, including content, spatial coherence 
and quality. This study showed that patients with schizophrenia produced fewer 
details about their scenes than controls, and their descriptions were judged to evoke 
less  clear  pictures  of  the  experiences  in  the  scorer’s  mind’s  eye.  The  same  group  
conducted a closely-related study in 2013 (Raffard, Esposito, Boulenger, & Van der 
Linden), but this time analysed the ability of the participants to generate specific 
details about positive and negative imagined future events separately. The results of 
their earlier study were replicated: imagined future events of both valences were less 
specific in the schizophrenia group than in the control group. Finally, in the study 
most closely related to the FTT (de Oliveira, Cuervo-Lombard, Salame, & Danion, 
2009) participants were asked to describe three plans they had for each of four time 
periods: the next week, month, 1 year and 5-10 years. For each plan they were asked 
to imagine a specific future event connected with the plan, and these were scored for 
specificity. Patients showed decreased ability to generate future plans, and future 
events connected with their plans were rated as less specific. 
 
The studies described above suggest that future-directed thinking in psychosis is 
impaired, both in the number of events that can be generated and in the detail 
associated with these events. However, several limitations are evident. First, the 
protocols used in the three studies varied, and therefore a consistent and well-
established measure of future-directed thinking such as the FTT would help to unify 
the research in this area. Second, cues were employed in two of the protocols, 
meaning that the future events generated by respondents were not spontaneously 




to measure the amount of detail that could be generated about a single response, rather 
than to measure the number of responses that could be generated in total, as in the 
FTT. Therefore the absolute capacity of respondents for generating future events was 
not measured. Fourth, illness duration in three of the studies was long: means of 14, 
11 and 9 years  were  reported  in  the  D’Argembeau  et al., Raffard et al. 2010 and 
Raffard et al. 2013 studies respectively (illness duration was not reported in the de 
Oliviera study). Finally, only the Raffard et al. 2013 study drew a distinction between 
ability to generate and describe positive scenarios and negative scenarios, and no 
study linked capacity to think about the future with either hopelessness or suicide. 
 
Notwithstanding the above limitations, these studies demonstrated that individuals 
with psychosis have impairments in thinking about the future that are relevant to the 
current discussion. On the basis of this evidence it may be predicted that individuals 
with first episode psychosis would have a reduced capacity for future-directed 
thinking, and as described in Section 1.4.4, reduced PFT in particular may be 
connected with hopelessness and the increased risk of suicide observed in this 
population. This prediction is partially supported by a study in which factor analysis 
was performed on BHS scores collected from individuals with schizophrenia (Kao, 
Liu, & Lu, 2012). After covarying for self-reported depression, individuals with and 
without suicidal ideation differed on a factor derived from the BHS described as 
“Negative  Expectation  Of  The  Future”.  This  factor  included  items  such  as  “the  future  
seems  vague  and  uncertain  to  me”,  “my  future  seems  dark  to  me”,  and  “I  have great 
faith  in  the  future” (scoring reversed), and it can be likened to reduced PFT due to the 
tendency in these items to deny optimism for the future. The groups did not differ on 




with individuals who had suffered from schizophrenia for an average of 15 years, 
highlighting the potential for extending this research to individuals in the early stages 
of psychosis. 
 
In summary, the current study proposes that reduced PFT is a component of global 
hopelessness that is reliably associated with an elevated risk of suicide in general and 
increased suicidal ideation in particular, and has the potential to be a practical addition 
to the assessment of suicide risk in first episode psychosis. Previous studies of 
individuals with psychosis have highlighted deficits in the specificity of future-
directed thinking but have not measured absolute capacity to generate future events or 
linked future-directed thinking to hopelessness and suicide. The current study was 
planned to address these gaps in the literature through the investigation of future-
directed thinking in first episode psychosis using a well-established task, the FTT. 
The aims and hypotheses of this study are given at the end of this chapter. To date, no 
published study has employed the FTT to measure future-directed thinking in people 
with psychosis. 
 
1.5 Future-directed thinking and negative symptoms of psychosis 
As well as being linked with suicide risk, hopelessness has also been shown to 
associate with the negative symptoms of psychosis. Negative symptoms describe 
functions that are diminished or lacking in those with psychosis but are usually 
present in the general population. Typical examples are reduced interest in previously 
enjoyed activities (anhedonia), reduced voluntary movement (avolition), and reduced 




significant functional impairment in psychosis (Breier, Schreiber, Dyer, & Pickar, 
1991) and reduced functional outcome at up to 10-year follow-up (Hassan & Taha, 
2011; Milev et al., 2005; Ventura et al., 2009; C. White et al., 2009). Furthermore, 
negative symptoms are often resistant to treatment (Buchanan, 2007; Buckley & 
Evans, 2006). 
 
Previous work has shown that negative symptoms in psychotic disorders correlate 
with self-reported hopelessness. In a study by Aguilar et al. (1997) 96 individuals 
with non-affective psychotic disorders including schizophrenia were assessed using 
the BHS and the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 
1981). BHS score was shown to be positively correlated with SANS score, indicating 
that as hopelessness increased, severity of negative symptoms also increased. 
Moreover, baseline hopelessness, but not baseline negative symptoms, predicted 
global functioning at 12-month follow-up, indicating that hopelessness may be key to 
the reduced functioning observed in those with more severe negative symptoms. 
 
Four more recent studies are of relevance to this argument. First, a study by Lysaker, 
Davis, and Hunter (2004) of 52 individuals with schizophrenia found no association 
between two domains of the BHS and negative symptoms measured by the Positive 
and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). However, in 
a second study by the same group (Lysaker, Salyers, Tsai, Spurrier, & Davis, 2008) a 
correlation was found, and negative symptoms contributed significantly to a model 
predicting hopelessness as measured by the BHS. The discrepancy in these results 
may be due to the larger sample in the later study (N = 143). Third, a study of 100 




(2007) compared groups with and without hopelessness as determined by a cut-off 
score of 9. They found that the group with hopelessness had significantly higher 
levels of negative symptoms than the group without hopelessness, though their 
between-groups approach is somewhat in contrast with the other studies of this 
relationship. Finally, recent work by Kao et al. (2012) also supports the link between 
hopelessness and negative symptoms. In a study of 102 outpatients with chronic 
schizophrenia, factors derived from the BHS were shown to correlate with negative 
symptoms as measured by the PANSS. Positive symptoms showed no relationship 
with either factor of the BHS. On balance, the literature supports the hypothesis that 
self-reported hopelessness is associated with severity of negative psychotic 
symptoms. However, it should be noted that of all the studies described here only the 
one by Aguilar et al. recruited individuals in their first episode of psychosis. 
Participants in the other studies described had mean illness durations of 13 (R. G. 
White et al., 2007), 16 (Kao et al., 2012) and 22 (Lysaker et al., 2004; Lysaker et al., 
2008) years (the latter figure is approximate, and is based on the figures reported for 
age at test minus age at first admission as specific illness duration was not reported). 
This highlights a need for more research into the link between hopelessness and 
negative symptoms in the early stages of psychotic illness. 
 
Taking the evidence described above together with the association between 
hopelessness and reduced PFT discussed previously, we can predict that reduced PFT 
may be related to severity of negative symptoms. This hypothesis also has a certain 
face validity, as one might expect decreased energy, activity and enjoyment to follow 
naturally if positive events, during or in pursuit of which these attributes might be 




study of individuals with schizophrenia by Raffard et al. (2013), which linked apathy, 
a negative symptom, with reduced ability to imagine pleasant future events. 
Participants were asked to generate and elaborate one specific event in response to 
each of a number of picture cues. The events that patients generated were rated as less 
specific than those of controls, and for positive events this was associated with 
increased apathy as measured by the Lille Apathy Rating Scale and the “apathetic / 
social withdrawal”  item  from  the  PANSS. Notably, specificity for imagined negative 
events was not associated with apathy. Further support comes from a study by 
Ferguson, Conway, Endersby, and MacLeod (2009), who demonstrated a concurrent 
improvement in both negative symptoms and positive future thinking following an 
intervention to increase subjective well-being. 
 
Previous studies of individuals with psychosis have shown that there is an association 
between self-reported hopelessness and negative symptoms, and there is evidence to 
suggest that future-directed thinking, especially PFT, may also be linked to negative 
symptoms. Further investigation of this issue may point to practical options for 
intervention in this hard-to-treat aspect of psychotic illness. The current study was 
designed to investigate these relationships using the FTT together with an assessment 
of negative symptoms. The associated aims and hypotheses are given below. 
 
1.6 Thesis aims and hypotheses 
This study aimed to investigate future-directed thinking in a novel population at high 
risk for suicide–individuals with first episode psychosis–and compare this with future-




investigate the association of future-directed thinking with hopelessness, suicide risk, 
and severity of negative symptoms of psychosis. There were five specific aims: 
Aim 1: To replicate previous work by demonstrating a relationship between self-
reported hopelessness and reduced positive future thinking across both groups; 
Aim 2: To investigate group differences in future-directed thinking between 
individuals with first episode psychosis and matched community controls; 
Aim 3: To characterise the content of future-oriented cognitions in first episode 
psychosis in comparison with those of community controls; 
Aim 4: To investigate the relationship between future-directed thinking and 
suicidal ideation in people with first episode psychosis; 
Aim 5: To investigate whether specific aspects of future-directed thinking were 
associated with negative symptoms in individuals with first episode psychosis.  
 
The study examined future-directed thinking in a new population and therefore 
predictions about the direction of expected effects were necessarily tentative. 
However, based on the findings of previous work described above, there were four 
hypotheses: 
Hypothesis 1: Self-reported hopelessness would show a significant relationship 
with decreased PFT but not increased NFT across groups; 
Hypothesis 2: Individuals with first episode psychosis would show reduced PFT 
in comparison with a matched control group but would show no increase in 
NFT; 
Hypothesis 3: Decreased PFT but not increased NFT in the first episode 




Hypothesis 4: Decreased PFT in the psychosis group would be associated with 
increased negative symptoms. 
The investigation of group differences in the content of FTT responses was an 








 Chapter  2: 
Method 
2.1 Ethical approval 
Ethical approval for this study was gained from the Camberwell St Giles Research 
Ethics Committee (reference number 13/LO/0876) and from the Royal Holloway, 
University of London Psychology Departmental Ethics Committee. Permission for 
recruitment was given by the Research and Development (R&D) departments of 
Barnet, Enfield and Haringey Mental Health NHS Trust, Cambridgeshire and 
Peterborough NHS Foundation Trust, South West London and St George’s  Mental  
Health NHS Trust, and West London Mental Health NHS Trust. Letters of ethical and 
R&D approval are given in Appendices 1 and 2, respectively. 
 
2.2 Design 
Participants completed tasks measuring verbal fluency and future-directed thinking, 
and self-report and clinician-administered questionnaires assessing anxiety, 
depression and hopelessness (both groups) and suicidal ideation and negative 
symptoms of psychosis (patients only). Two statistical designs were employed. First, 
individuals with a first episode of psychosis and controls were compared on positive 
and negative future-directed thinking for a variety of time periods using a mixed-
model design. Second, a cohort design was used to assess the relationship of future-
directed thinking to suicidal ideation and negative symptoms of psychosis in the 





2.3 Power calculation 
No previous data were available on the effect size of group differences in future 
thinking between individuals with psychosis and controls. However, calculations 
based on research into other clinical populations, such as individuals with bulimia 
(Godley, Tchanturia, MacLeod, & Schmidt, 2001) and depression (MacLeod, 
Pankhania, et al., 1997), suggested that the effect size in question was large (Cohen, 
1988). To achieve 80% power to detect a large effect at an alpha level of 5%, a 
sample size of 26 per group was necessary for the between-groups part of the study. 
 
There were no previous data available to guide predictions about the size of 
correlations between positive future thinking and negative symptoms or suicidal 
ideation. However, studies of the correlation between self-reported hopelessness and 
suicidal ideation have shown a large effect size (Kao et al., 2012; O'Connor et al., 
2008). To achieve 80% power to detect a large correlation at an alpha level of 5%, a 
sample size of 29 within the psychosis group was needed. 
 
2.4 Participants and recruitment 
Two groups of participants were recruited into the study: individuals within 12 
months of their first episode of psychosis and matched controls with no history of 
psychosis. Psychosis was defined by the presence of positive symptoms such as 
delusions, hallucinations, thought disorder as indicated by disorganized speech, and 
grossly disorganized or catatonic behaviour, as outlined in DSM-IV-TR (American 
Psychiatric Association, 2000; McGorry, Edwards, Mihalopoulos, Harrigan, & 




present at the time of testing, but a decision must have been made by the treating team 
(including a psychiatrist) that clinically significant symptoms of psychosis had been 
present in the previous 12 months, that is, that the individual had experienced a first 
episode of psychosis. Full inclusion and exclusion criteria are given in Table 2.1. 
Fifty-seven participants were recruited into the study: thirty patients and twenty-seven 
controls. 
 
Patient participants were recruited from Early Intervention (EI) services in the 
London boroughs of Hammersmith and Fulham, Haringey, Merton and Sutton (served 
by one service), and in the county of Cambridgeshire. Recruitment of participants to 
the psychosis group began with initial screening of caseloads by individual care-
coordinators in the EI services. Care-coordinators informed the researcher of any 
individuals who met the research criteria (see Table 2.1) and initiated contact. Patients 
who consented to be contacted by the researcher were contacted by phone, at which 
time the study was described to them and the study information sheet was sent by 
post, email or via the care-coordinator. The information sheet for patient participants 
is shown in Appendix 3. If, after reading the information sheet, the proposed 
participant was agreeable to taking part they were invited to attend for the study 
session. The final patient sample consisted of nine females and 21 males, with a mean 
age of 26.6 years (range = 19-35 years, SD = 4.7). Mean time since referral to the 
team was 6.1 months (SD = 3.26), with a range from 2 to 12 months. The number of 







Table 2.1. Inclusion and exclusion criteria for all participants. 




Experience of a first episode of any 
psychotic disorder including 
features given in Criterion A for 
schizophrenia in DSM-IV-TR: 
delusions, hallucinations, 
disorganised speech, grossly 
disorganised or catatonic 
behaviour, or negative 
symptoms. 
Psychotic illness not meeting criteria 
for first episode, e.g. participant 
presented to clinical services or 
was treated with antipsychotic 
medication more than 12 
months prior to testing. 
 Presented to clinical services less than 
12 months prior to testing. 
 
Psychosis had a confirmed organic 
cause. 
Controls Matched for age and gender with a 
member of the FEP group. 
  
History or presence of psychotic 
disorder. 
All groups Provided written informed consent. Presence of learning disability. 
 Able to comprehend the key 
components of the consent form. 
Visibly intoxicated by alcohol or other 
illicit drugs at the time of testing. 
 Able to read and write in English at a 








Table 2.2. Number of participants recruited from each EI service. 
Region Participants 
Cambridgeshire 7 
Hammersmith and Fulham 10 
Haringey 4 
Merton & Sutton 9 
 
Control participants were recruited from regions within a convenient travelling 
distance of Central London. They were recruited via poster, leaflet and online 
classified advertising. The poster and leaflet are reproduced in Appendix 4. 
Volunteers interested in taking part were invited to contact the researcher via contact 
details given in the advertising material. Upon contact, a telephone screening 
conversation was arranged, during which the study was described to them and their 
eligibility was assessed against the research criteria (see Table 2.1). They were asked 
whether they had a history of or current psychotic disorder, and basic demographic 
details (age, gender) were collected for the purposes of matching to the patient group. 
Eligible individuals were sent the information sheet via email, and if after reading this 
they were still agreeable to participating they were invited to attend for the study 
session. The information sheet for control participants is shown in Appendix 5. The 
control group was matched to the patient group on age and gender as far as possible. 
The final control sample consisted of seven females and 20 males, with a mean age of 






2.5.1 Demographic data 
Demographic information was collected from each participant verbally: participants 
were asked their date of birth, gender, education level, employment status, first 
language and ethnicity. Answers for education level, employment status, first 
language and ethnicity were recorded verbatim and then coded into categories. 
Education level was coded into one of nine categories depending on the highest 
qualification obtained by the participant. The categories ranged from 0 = Entry level 
or no qualifications, to 8 = doctorate, NVQ level 5 or equivalent (Office of 
Qualifications and Examinations Regulation, 2012). The full table of educational 
equivalent levels is given in Appendix 6. Employment status was coded into 
employed (full or part time) and not employed (full-time student, full-time parent or 
unemployed). First language was coded into two groups: English or not English. 
Ethnicity was coded into one of five major categories: White; Mixed / Multiple Ethnic 
Group; Asian / Asian British; Black / African / Caribbean / Black British; and Other 
Ethnic Group, as recommended by the Office for National Statistics for use in 
England (Office for National Statistics). The number of months since first referral to 
their EI service was collected for each patient as a proxy measure of time since onset 
of psychosis. 
 
The variables measured during the research protocol are shown in Table 2.3, and full 






Table 2.3. Variables tested and the measures used, with abbreviations. 
Variable Measure Abbreviation 
Variables of main interest 
Future-directed thinking Future Thinking Task FTT 
Hopelessness Beck Hopelessness Scale BHS 
Risk of suicide Beck Scale for Suicide Ideation SSI 




Depression Calgary Depression Scale for 
Schizophrenia 
CDSS 
Anxiety Generalized Anxiety Disorder scale GAD-7 
Verbal fluency FAS test N/A 
Note. N/A = not applicable 
 
2.5.2 Future Thinking Task 
The future thinking task is an adapted fluency task in which participants are asked to 
generate events that they anticipate will happen to them in the future in each of three 
different time periods: the next week, the next year, and the next five to ten years. 
Two trials are administered for each time period, one in which participants are asked 
to generate positive events (events they are looking forward to), and one in which 
they are to generate negative events (events they are not looking forward to), therefore 
there are six trials in total. Each trial lasts for one minute and the participant is 
encouraged to keep trying to generate events throughout the whole trial. 





Now  I’m  going  to  ask  you  to  tell  me  about  things  that  you  think  might  happen  to  
you in the future. I will give you three different time periods in the future, one at a 
time,  and  I’d  like you to try to think of things that might happen to you in those 
time periods. I will give you one minute to tell me as many things as you can. It 
doesn’t  matter  whether  the  things  you  tell  me  are  big  and  important  or  small  and  
insignificant, just say what comes to mind. But they should be things that you 
think will definitely happen or are at least quite likely to happen. If  you  can’t  think  
of  many  things  that’s  fine,  just  keep  trying  until  I  tell  you  the  time  is  up. We will 
do it six times altogether. 
 
At this juncture the researcher checked for understanding and repeated parts of the 
instructions as required. The following instruction was given before each trial. 
(Alternative instructions are marked by square brackets and were interchangeable 
depending on the trial.) 
 
[First / Next],  I’m  going  to  ask  you  to  think  of  [positive  /  negative]  things  in  the  
future, things that you are looking forward to, things that you will enjoy. I want 
you  to  tell  me  as  many  things  as  you  can  that  you’re  looking  forward  to in the 
coming [week, including today / year / five to ten years]. Your time starts now. 
 
All trials of a given valence were presented consecutively and ordered as written, and 
the order of presentation of the positive and negative conditions was counterbalanced 
across participants. Each response was written down by the researcher. Following 




rate the likelihood of each event and how they would feel if it were to occur, both on a 
seven-point Likert scale. The likelihood rating scale was anchored by 1 = not at all 
likely to 7 = extremely likely. The feelings rating scale was anchored by -3 = very 
unhappy to +3 = very happy. 
 
A composite score was calculated for each trial in the FTT by multiplying the mean 
likelihood and feelings ratings for each trial by the total number of events generated in 
that trial. Thus, for a person who generated five things that they were looking forward 
to in the next week, gave a mean likelihood rating for those items of 6, and gave a 
mean happiness rating for those items of 2.5, the composite PFT score for 1 week 
would be 75 (5 x 6 x 2.5). To facilitate the comparison of composite scores between 
positively- and negatively-valenced trials, composite scores for the negatively-
valenced trials were multiplied by -1 (see MacLeod et al., 2005). Outcome measures 
for the performance aspect of the FTT were the number of events generated (FTT-
number) and composite score (FTT-composite).  
 
Content of the events generated in the FTT 
The content of the events generated in the FTT were coded into domains using a 
system adapted from the Quality of Life Scale devised by Flanagan (1978). This scale 
was used because it has been shown to represent those aspects of life that are 
important to people in a large study of 3000 individuals from a wide range of ages and 
ethnicities (Flanagan, 1978). It also measures quality of life not only in relation to 
health outcomes, but in a wide range of domains. It has been shown to have good 
internal consistency (Burckhardt, Woods, Schultz, & Ziebarth, 1989) and construct 




major domains of quality of life, based on categorisation of events, experiences and 
behaviours listed by respondents as important in their lives. These were: A. Physical 
and Mental Well-Being; B. Relations with Other People; C. Social, Community and 
Civic Activities; D. Personal Development and Fulfilment; and E. Recreation. In this 
study the Recreation category is adapted to take account of non-recreational activities, 
and renamed Activities. Each category is described below, and in instances where the 
domain was adapted to take account of unique responses given in the current study 
this is described. Table 2.4 shows examples of positive and negative items in each 
category generated by participants in the study.  
 
A. Physical and material well-being 
This domain includes events relating to material well-being and financial security, 
such as having a home, food and possessions, physical and mental health and well-
being, and personal safety. 
 
B. Relations with other people 
This domain includes relationships with a significant other, the expectation of having 
children and its attendant activities, relationships with parents and other family 
members, and relationships with friends. Any response where an activity with a 
person in the above categories was mentioned was coded into this domain, regardless 
of other content. In the current study, responses in which a relationship with another 
person of any kind was the focus of the item were also coded into this domain, even if 






Table 2.4. Sample answers given in each of the future-directed thinking categories. 
    Example responses 
Category example Positive Negative 
Physical and mental well-being 
 
1 week Being healthy Being homeless 
 
1 year Buying a car Having no money 
 
5-10 years Buying a house Getting older 
Relations with other people 
 
1 week Seeing my family Arguing with my mum 
 
1 year Getting married My relationship ending 
 
5-10 years Having children Losing touch with friends 
Social, community and civic activities 
 
1 week Making people smile Volunteering 
 
1 year Becoming a godmother Not gaining UK residency 
 
5-10 years Adopting British Nationality Going to prison 
Personal development and fulfilment 
 
 
1 week Writing poetry Not living independently 
 
1 year Getting promoted Being unemployed 
 
5-10 years Starting my own business Having more responsibility 
Activities 
 
1 week Playing videogames Going to the gym 
 
1 year Running a marathon Having a limited social life 





example was relationships with colleagues. For example, one respondent was not 
looking forward to having a difficult conversation with a work colleague. This could 
be conceptualised as an item relating to occupational role, and thus coded into the 
Personal Development and Fulfilment category (see below). However, the clear focus 
of the item was a conversation with another person, therefore it was deemed 
appropriate to categorise this item as into Relations With Other People. 
 
C. Social, community and civic activities 
This domain includes activities related to helping or encouraging other people (other 
than significant other, family or close friends), and activities relating to local and 
national governments. 
 
D. Personal development and fulfilment 
This domain includes items concerning intellectual development, personal 
understanding and planning, occupational role, and creativity and personal expression. 
In the current study, responses focusing on gaining or having independence and 
autonomy were also coded into this domain. It was considered that these items 
represented a manifestation of personal planning and fulfilment, and therefore were 
appropriate for this domain. 
 
E. Activities 
This domain includes items such as socialising (distinct from relationships with 
individual friends), passive and observational recreational activities, and active and 
participatory recreational activities. In the current study activities not usually done for 




travel (e.g. commuting) and doing laundry. This decision was made because on 
several occasions respondents reported looking forward to everyday activities of this 
kind, and therefore they could be conceptualised as recreational for these individuals. 
It seemed inconsistent, though, to code these items into a different category when they 
were not looked forward to. A common example was cooking. Some respondents 
enjoyed cooking and therefore it was logical to code this as a recreational activity. 
However, cooking is also an everyday activity that is not enjoyed by everybody, thus 
this item posed a problem when respondents reported that they were not looking 
forward to it. Moreover, items such as cooking and functional travel were not better 
accounted for by another category. The best compromise seemed to be to include all 
activities not involving another specified person (which would tend to code into the 
Relations with Other People category) into the Recreation category, and to 
reconceptualise it as representing all activities, rather than recreation alone. 
 
Outcome measures for the content aspect of the FTT were the numbers of items 
generated in each category. Inter-rater reliability of coding was calculated by having a 
second rater, blind to group membership, categorise the responses from a random 
10% of participants (158 items). The inter-rater agreement was kappa = .98, 
indicating a high level of agreement between the raters. 
 
2.5.3 Hopelessness 
The BHS was used as a measure of self-reported hopelessness. It is a 20 item (true or 
false) self-report  scale  measuring  expectancies  about  one’s  future.  Participants  are  
asked to indicate whether each statement describes their attitude for the past week 




negatively  phrased  (e.g.  “My  future  seems  dark  to  me”)  and  nine  items  are  positively  
phrased  (e.g.  “I  have  great  faith  in  the  future”).  Higher  scores  indicate  a  higher  level  
of hopelessness, up to a maximum score of 20. The outcome measure used was total 
BHS score. A cut-off score of 9 has been shown to give a sensitivity of .80 for the 
prediction of completed suicide, but this is offset by low specificity of .42 (McMillan 
et al., 2007). A copy of the BHS is provided in Appendix 7. 
 
The BHS is a well-established instrument with good internal consistency (Kuder-
Richardson  Formula  20,  equivalent  to  Cronbach’s  alpha = .93). A similarly high level 
of internal consistency was demonstrated  in  the  current  study  (Cronbach’s  
alpha = .91). Concurrent validity of the BHS is supported by its relatively high 
correlation with clinical ratings of hopelessness and other self-administered measures 
of hopelessness such as the Stuart Future Test and the pessimism item of the Beck 
Depression Inventory (Beck, Weissman, et al., 1974). The construct validity of the 
BHS is supported by studies in which it has been used to test hypotheses relevant to 
the construct of hopelessness. For example, in one study negative expectancies of the 
future (i.e. hopelessness) were shown to be linked to clinical symptoms of depression, 
and in another the seriousness of suicidal intent was shown to correlate more highly 
with negative expectancies of the future than with depression (Beck, Weissman, et al., 
1974). The confirmation of these hypotheses, investigated using the BHS, attests to 
the construct validity of the scale. 
 
2.5.4 Risk of suicide 
Risk of suicide was measured using the Beck Scale for Suicide Ideation (SSI), self-




ideation in inpatients and outpatients. Each item consists of a set of three statements 
and the participant must endorse the one that best describes how they have been 
feeling for the past week including the day of testing. Each statement carries a score 
from 0-2, with a higher score indicating increased suicide ideation up to a maximum 
of  42.  For  example,  Item  1  contains  the  statements:  “I  have  a  moderate  to  strong  wish  
to  live”  (scores  0),  “I  have  a  weak  wish  to  live”  (scores  1)  and  “I  have  no  wish  to  live”  
(scores 2). Items 1-19 assess current suicide ideation, and Items 20 and 21 assess 
historic suicide attempts and intent. All participants are required to answer the first 
five items. Items 4 and 5 act as an internal screening component: if a participant 
scores above zero on either of these items they must go on to complete the whole 
questionnaire. A score of zero on both of these items means that only Items 20 and 21 
must be completed in addition to the first five. The outcome measure used was total 
SSI score. No cut-off scores are given for the SSI, as the risk of suicide is extremely 
problematic to quantify and must be evaluated in the context of a range of factors and 
assessments. As such, the SSI is intended for use as part of a full risk assessment 
(Beck & Steer, 1991). A copy of the SSI is provided in Appendix 8. 
 
The SSI has been shown to have high internal consistency (Cronbach’s  alpha  =  .93;;  
Beck, Steer, & Ranieri, 1991), and this was replicated in the present sample 
(Cronbach’s  alpha = .93). The clinician-administered SSI has been shown to have 
moderately high correlations with clinical evaluations of suicidal risk (Beck, Kovacs, 
& Weissman, 1979) and the self-report version is highly correlated with the clinician-
administered version (Pearson’s  r = .90) making it a practical substitute for a longer 
clinical interview and indicating that the SSI has good concurrent validity. The 




between hopelessness, depression and suicidal ideation as measured by the SSI (Beck 
et al., 1991), and another that indicated that increased scores on the SSI were 
associated with less favourable ratings of the  concept  of  “life”  (Beck, Kovacs, et al., 
1979). 
 
2.5.5 Negative symptoms of psychosis 
Severity of negative symptoms was measured in the patient group using the SANS 
(Andreasen, 1981, 1982). The SANS is administered via a semi-structured interview 
with the respondent covering topics such as how the individual has been spending 
their time, the quality of their relationships with others, motivation, and energy. The 
time period for consideration was 1 month. Ratings are made on the basis of the 
respondent’s  answers and observations made by the administrator over the course of 
the interview. Ratings are made on 25 items from five subscales: Affective Flattening 
or Blunting (e.g. Item 5: Affective Nonresponsivity), Alogia (e.g. Item 9: Poverty of 
Speech), Avolition-Apathy (e.g. Item 14: Grooming and Hygiene), Anhedonia-
Asociality (e.g. Item 18: Recreational Interests and Activities), and Attention (e.g. 
Item 23: Social Inattentiveness). Each item is rated on a 6-point scale from 0 = not at 
all, to 5 = severe, thus higher scores indicate greater severity of negative symptoms, 
up to a maximum of 125. The outcome measure used was total SANS score. Two 
example items are given below. The first (Item 1) is rated by observation throughout 





Item 1: Unchanging Facial Expression (Affective Flattening or Blunting 
subscale) 
The  subject’s  face  appears  wooden,  mechanical,  frozen.  It  does  not  change  
expression, or changes less than normally expected, as the emotional content of 
discourse  changes.… 
0 Not at all: Subject is normal or labile; 
1 Questionable decrease; 
2 Mild:  Occasionally  the  subject’s  expression  is  not  as  full  as  expected;; 
3 Moderate:  Subject’s  expressions  are  dulled  overall,  but  not  absent;; 
4 Marked:  Subject’s  face  has  a  flat  ‘set’  look,  but  flickers  of  affect  arise  
occasionally; 
5 Severe:  Subject’s  face  looks  ‘wooden’  and  changes  little,  if  at  all  
throughout the interview (Andreasen, 1981, p. 4). 
 
Item 21: Relationships with Friends and Peers (Anhedonia-Asociality 
subscale) 
Subjects may also be relatively restricted in their relationships with friends and 
peers of either sex. They may have few or no friends, make little or no effort to 
develop such relationships, and choose to spend all or most of their time alone. 
[Ask  the  participant]  ‘Have you been spending much time with friends? Do you 
enjoy spending time alone, or would you rather have more friends?’ 
0 No inability to form close friendships; 
1 Questionable inability to form friendships; 




3 Moderate: subject able to interact, but sees friends/acquaintances only two 
to three times per month; 
4 Marked: Subject has difficulty forming and/or keeping friendships. Sees 
friends/acquaintances only one to two times per month; 
5 Severe: Subject has no friends and no interest in developing any social ties 
(Andreasen, 1981, p. 18). 
 
The SANS ideally incorporates information from additional sources such as nurses, 
clinical notes or family members. Due to time limitations, collecting collateral 
information was not possible in the current study. Scores on the SANS have been 
linked with scores on the Clinical Global Impression (CGI), although a perfect one-to-
one relationship between the scales was not demonstrated (Levine & Leucht, 2013). 
Scores of up to 56 were found to correspond to normal to borderline illness in the 
CGI, scores of 37-66 corresponded to mild-to-moderate illness on the CGI, and scores 
of over 63 corresponded to marked, severe and extreme illness on the CGI. The full 
SANS is reproduced in Appendix 9. 
 
The SANS has high internal consistency  (Cronbach’s  alpha  =  .89),  though  in  the  
present  sample  this  was  found  to  be  moderate  (Cronbach’s  alpha = .73) , possibly due 
to invariance on Item 8: Inappropriate Affect. Concurrent validity of the SANS is 
confirmed by the presence of a significant correlation with the negative symptom 
subscale of the Positive and Negative Symptom Scale (Spearman's rho = .56, p < 
.001; Rabany, Weiser, Werbeloff, & Levkovitz, 2011). Construct validity of the 
SANS is supported by the association of higher SANS scores with reduced 






The Calgary Depression Scale for Schizophrenia (CDSS) was used to measure 
depression in both groups of participants. This scale was chosen because it 
differentiates depressive symptoms from other symptoms of schizophrenia, and is also 
valid for use in populations without schizophrenia (Muller et al., 2005). The CDSS is 
a nine-item scale, administered via a semi-structured interview. Initial and follow-up 
questions are given for each item, with the initial question to be asked as written and 
the follow-up  questions  to  be  used  at  the  administrator’s  discretion.  Respondents  are  
asked to base their answers on their experiences over the past 2 weeks. The first eight 
items are rated on the basis of their answers, and the final item (Observed Depression) 
is  based  on  the  interviewer’s  observations  during  the  interview.  Items  are  rated  by  the  
researcher on a 4-point scale from 0 = absent, to 3 = severe, thus higher scores 
indicate more severe depression, up to the maximum score of 27. The outcome 
measure used was total CDSS score. Two example items are given below.  
 
Item 1: Depression 
How would you describe your mood over the last two weeks? Do you keep 
reasonably cheerful or have you been very depressed or low spirited recently? In 
the last two weeks how often have you (own words) every day? All day? 
0 Absent; 
1 Mild: Expresses some sadness or discouragement on questioning; 
2 Moderate: Distinct depressed mood persisting up to half the time over last 




3 Severe: Markedly depressed mood persisting daily over half the time 
interfering with normal motor and social functioning (D. Addington, 
Addington, Matickatyndale, & Joyce, 1992, p. 206). 
 
Item 4: Guilty Ideas of Reference  
Do you tend to blame yourself for little things you may have done in the past? Do 
you think that you deserve to be so concerned about this? 
0 Absent; 
1 Mild: Subject sometimes feels over guilty about some minor peccadillo, 
but less than 50% of time; 
2 Moderate: Subject usually (over 50% of time) feels guilty about past 
actions the significance of which he exaggerates; 
3 Severe: Subject usually feels s/he is to blame for everything that has gone 
wrong, even when not his/her fault (D. Addington et al., 1992, p. 207). 
 
A score of 7 on the CDSS has an 82% specificity and 85% sensitivity for predicting 
the presence of a major depressive episode (D. Addington, Addington, & Maticka-
Tyndale, 1993). The CDSS is freely available at http://www.ucalgary.ca/cdss and the 
full scale is shown in Appendix 10.  
 
A recent review of reliability and validity of scales measuring depression in 
schizophrenia reported the psychometric properties of the CDSS (Lako et al., 2012). 
The CDSS was shown to have high  internal  consistency  (Cronbach’s  alpha = .82), 
which  was  confirmed  in  the  current  study  (Cronbach’s  alpha  =  .80).  Inter-rater 




high. Good concurrent validity was evidenced by strong correlations with other 
measures of depression including the Hamilton Depression Scale (r = .74), the Beck 
Depression inventory (r = .83), and the PANSS depression subscale (r = .66; Lako et 
al., 2012). Construct validity is supported by the ability of the CDSS to predict the 
presence of a major depressive episode (D. Addington et al., 1992). 
 
2.5.7 Anxiety 
The General Anxiety Disorder questionnaire (GAD-7) is a well-established and 
quickly administered self-report scale for anxiety symptoms (Spitzer, Kroenke, 
Williams, & Lowe, 2006). Participants are asked to rate the frequency of their 
experience  of  seven  common  symptoms  of  anxiety  such  as  “Feeling nervous, anxious 
or  on  edge”  and  “Having  trouble  relaxing”  over  the  past  week.  Responses  are  given  
on a 4-point scale from 0 = not at all to 3 = nearly every day. Higher scores indicate 
greater levels of anxiety, up to the maximum score of 21. The outcome measure used 
was total GAD-7 score. A clinical cut-off of 8 is recommended for the identification 
of clinical anxiety (IAPT National Programme Team, 2011). This cut-off is reported 
to identify clinical anxiety with 92% sensitivity and 76% specificity (Spitzer et al., 
2006). A copy of the GAD-7 is provided in Appendix 11. 
 
The GAD-7 has excellent  internal  consistency  (Cronbach’s  alpha = .92), and this was 
confirmed  in  the  current  sample  (Cronbach’s  alpha = .92). Concurrent validity is 
supported by correlations with the Beck Anxiety Inventory (r = .72) and the anxiety 
subscale of the Symptom Checklist-90 (r = .74), and construct validity is evidenced 
by the association of the GAD-7 with worsening function in the Symptom Checklist-





2.5.8 Verbal fluency 
Verbal fluency was assessed using the FAS test (Lezak, Howieson, & Loring, 2004). 
In this task participants are asked to generate words beginning with a given letter–F, 
A or S–in three separate trials. They are given one minute per trial to generate as 
many words as possible. Proper nouns are not permitted, and multiple words 
involving the same stem word (e.g. run, runner, running) score only once. The trials 
were always administered in the same order: first F, then A, then S. The outcome 
measure used was the total number of words generated across the three trials. 
 
Internal  consistency  of  the  FAS  test  has  been  shown  to  be  high  (Cronbach’s  
alpha = .83),  and  in  the  current  sample  internal  consistency  was  excellent  (Cronbach’s  
alpha = .91). Construct validity is supported by the sensitivity of FAS score to lesions 
in the frontal lobe, temporal lobe, and caudate nucleus, and to the presence of 
Huntington’s  disease,  amnesia  and  traumatic  brain  injury.  Test-retest reliability has 




2.6.1 Data collection 
Data were collected between December 2013 and April 2014. All data were collected 
by the chief investigator and author, EG, who had suitable training and experience in 
the testing methods. Research sessions for patient participants were conducted on site 




convenience, and in case their responses revealed risk issues that needed to be dealt 
with by the duty clinician. Research sessions for control participants were conducted 
at the Royal Holloway Central London location. 
 
2.6.2 Research interview 
Before testing commenced participants had an opportunity to ask any outstanding 
questions about the research session and review the study information sheet. Written 
informed consent was then obtained from each participant. The consent form was the 
same for both groups and is reproduced in Appendix 12. Demographic details were 
collected first, followed by administration of the FAS test to orient participants to the 
nature of fluency tasks. The FTT was administered next. The order of presentation of 
the positive and negative conditions in the FTT was counterbalanced across 
participants. A short interview about symptoms of depression (both groups) and 
negative symptoms (patient group only) followed, to facilitate scoring of the CDSS 
and SANS. The initial question given for each CDSS item was asked, followed by the 
follow-up questions as appropriate. During interviews with patient participants, 
questions relevant to the SANS were integrated into the conversation where 
appropriate to the topic of discussion, or else asked after the completion of the CDSS. 
The self-report measures and questionnaires were administered last to prevent priming 
effects on the FTT. The GAD-7 was administered followed by the BHS. For control 
participants testing ended here. For patient participants the SSI followed the BHS, at 
which point testing was complete. The procedure lasted for between 45 and 60 





Following testing all participants were given a debriefing document reiterating the 
purpose of the study and listing the names and contact details of organisations 
offering further help and information if needed. Debrief sheets for patient participants 
gave  details  of  the  relevant  Trust’s  crisis  procedure.  An  example  debrief  sheet  is  
shown in Appendix 13.  
 
2.6.3 Data analysis 
Data were scored by the researcher, and analysed using the Statistical Package for the 






 Chapter  3 
Results 
3.1 Data screening 
3.1.1 Data inclusion 
Thirty patient participants completed at least the FTT, meaning that their data could 
be used in the following analysis. Of these 30, one did not complete the SSI, but 
consented to the rest of their data being included in the analysis. One patient 
participant, additional to the 30 included in the analysis below, began the study 
session but took markedly longer than average on the tasks and did not complete the 
FTT within one session. The participant did not attend for a second session and their 
data are not included in any part of the analysis. All other patients and all 27 controls 
provided complete datasets. 
 
3.1.2 Data distribution: normality 
Before analysis commenced, data on continuous variables were screened for deviation 
from the normal distribution. Standardized z-scores for skewness and kurtosis were 
calculated for each variable. A score of 2.58 or more, corresponding to a p-value of 
less than .01, was considered to indicate significant deviation from the normal 
distribution (Field, 2009, Chapter 5). 
 
Significant positive skew was demonstrated in several of the FTT performance 
variables in the control group, including FTT-composite for positive valence, 5-10 
years (z = 2.99); negative valence, 1 week (z = 4.06); and negative valence, 1 year 




mean in each of these variables was responsible for the observed skew. The outlying 
scores were Winsorized, that is, they were changed manually to the value of the next 
highest score plus one unit of measurement. This was balanced by repeating the 
procedure at the opposite end of the distribution. After Winsorizing, these four 
variables were no longer significantly skewed. Significant positive skew was also 
evident in FTT-composite for positive valence, 1 week (z = 2.79), but there were no 
extreme outliers in this variable. ANOVA is considered robust to violations of the 
assumption of normality especially when sample size approaches 30 (Field, 2009, 
Chapter 10), therefore as the skew was not extreme and this was the only remaining 
skewed variable of the FTT, it was considered more satisfactory to analyse this 
variable unchanged than to transform it in isolation. 
 
Significant positive skew was shown in eight of the FTT content categories, and 
significant kurtosis was shown in three. In the case of these variables, inspection of 
the data showed that outliers were not always responsible for the skew, therefore 
Winsorizing was not appropriate. Square-root and log10 transformations improved but 
did not eliminate the skew and kurtosis, therefore it was decided that non-parametric 
tests would be used to compare groups on FTT content variables. 
 
Significant positive skew was demonstrated in the BHS scores of the control group 
(z = 2.75). A square-root transformation was performed on the data for both groups, 
which restored the distribution of the control group to normal and did not unduly 
affect the skew of the patient group. The transformed variable was used in all of the 





Significant positive skew and kurtosis were present in the SSI scores of the patient 
group due to a high number of zero scores (47%). Skew and kurtosis were 
ameliorated by square root and log10 transformations but these transformations were 
unable to affect the zero scores and thus the data continued to tend to cluster towards 
zero after transformation. For this reason it was decided to code SSI scores into zero 
and non-zero groups and use this binary variable in subsequent analyses in place of 
the continuous SSI variable. Fourteen people had zero scores, and sixteen had non-
zero scores. More details are shown in Section3.6. 
 
3.1.3 Data distribution: variance ratio 
Before data analysis commenced, data on continuous variables were screened for 
differences in group variance. Variance ratios between groups were calculated for 
each  variable  and  compared  to  the  Hartley’s  critical  value  (Fmax) of 2.07 for group 
size of 30 (Field, 2009, Chapter 5). Variance ratios greater than Fmax = 2.07 were 
considered to indicate a significant difference in group variances. 
 
Significant group differences in variance were found in FTT-number, positive 
valence, 1 year (Fmax = 2.32) and FTT-composite, positive valence, 1 year 
(Fmax = 2.77). In both cases the control (smaller) group had the larger variance, which 
would be expected to make ANOVA F-ratios more liberal (Field, 2009, chap. 10). It 
was decided to proceed with parametric tests despite differences in group variances as 
only one of the six variables entered into each of the analyses was affected by this 
problem. It was noted that results should be interpreted with caution, and post hoc 





Significant group differences in variance were found in two FTT content variables: 
Activities, positive valence (Fmax = 2.62) and Social Community and Civic Activities, 
negative valence (Fmax = 7.08). Controls had the larger variance in both cases, which 
would be expected to make the ANOVA F-ratio more liberal. On the basis of these 
results and the significant deviations from normality also observed, it was decided to 
test for group differences in FTT content using non-parametric tests. 
 
Significant differences between group variances were shown for CDSS (Fmax = 4.24) 
and GAD-7 (Fmax = 3.47). The patient group had the larger variance in both cases. 






3.2 Demographics of the study population 
The demographic profile of the 30 patients and 27 controls is shown in Table 3.1. 
Group differences in age, verbal fluency, CDSS score, and GAD-7 score were 
investigated using t-tests. Group differences in education level, which was measured 
on an ordinal scale, were tested for using a Mann-Whitney test. Group differences in 
all other variables, which were categorical, were tested for using chi-squared  (χ2) tests 
or  Fisher’s  Exact  Test  (FET;;  used  where  contingency  tables  were 2 × 2 or where the 
expected value in a cell was less than 5). As in all of the analyses described in this 
chapter, tests were two-tailed and used a 5% significance level. Where appropriate, 
separate  variance  estimates  were  used  where  Levene’s  test  indicated that variances 
were unequal. Where appropriate, the assumptions of regression were tested. For all 
regression analyses, the assumptions of linearity, multicollinearity, and independence 
were adequately met. Multicollinearity of predictors was tested using collinearity 
diagnostics including verifying that tolerances were greater than .1, variance inflation 
factor values were close to 1, and that no two predictors had high variance proportions 
on the same small eigenvalue. Additionally for linear regression, independence of 
errors was verified using the Durbin-Watson test and found to be satisfactory in all 
cases (values close to 2). 
 
3.2.1 Age 
Groups did not differ significantly on age (t(55) = 0.66, p = .515). The mean and 






Table 3.1. Demographic summary of participants in each group. 
Demographic Patientsa Controlsb 
Age, mean (SD) 26.6 (4.7) 27.3 (4.1) 
Age range 19-35 19-33 
Gender, n (%)   
Male 21 (70) 20 (74) 
Female   9 (30)   7 (26) 
Educational level, median (range)    3 (1-8)    6 (0-6) 
Employment, n (%)   
Employed   9 (30) 15 (56) 
Not employed 21 (70) 12 (44) 
Ethnic group, n (%) 
  White 19 (63) 19 (70) 
Mixed / Multiple ethnic groups 2 (7) 0 (0) 
Asian / Asian British   5 (17) 2 (7) 
Black / African / Caribbean / Black British   4 (13) 6 (22) 
Other ethnic group 0 (0) 0 (0) 
First language, n (%)   
English 22 (73) 17 (63) 
Not English 8 (27) 10 (37) 
Verbal fluency total score, mean (SD) 25.4 (9.6) 34.2 (11.9) 






Groups did not differ significantly in gender (p = .776, FET). Both groups had a 
majority of male participants. The number of males and females in each group are 
shown in Table 3.1. 
 
3.2.3 Education 
Groups differed significantly in Ofqual equivalent education level (U = 211.0, z =  
-3.20, p = .001; see Appendix 6 for full details of each level). Specifically, the control 
group had a higher level of education (M = 5, equivalent to foundation degree and 
diploma level) than the patient group (M = 3,  equivalent  to  ‘A’  level). The median and 
range of educational level for each group is shown in Table 3.1. 
 
3.2.4 Employment status 
Groups did not differ significantly in employment status, but this test approached 
significance  (χ2(1) = 3.80, p = .051). The number of participants in each employment 
group is shown for each of the two study groups in Table 3.1. 
 
3.2.5 Ethnic group 
Groups did not differ significantly in ethnic group (p = .412, FET). The number of 





3.2.6 First language 
Groups did not differ significantly on first language, which was coded as English or 
not English (p = .569, FET). The number of participants speaking English vs. another 
language as a first language is shown for each group in Table 3.1. 
 
3.2.7 Verbal fluency 
Groups differed significantly on FAS total score (t(55) = 3.08, p = .003). Specifically, 
the control group scored higher on the FAS test than did the patient group. Means and 
standard deviations for this measure are shown in Table 3.1. As the FTT is based on 
tests of verbal fluency, positive and negative FTT-composite scores were tested for 
correlation with FAS score. FTT-composite was significantly correlated with FAS 
score in both the positively- (r = .55, p < .001) and negatively-valenced (r = .36, 
p = .005) trials. 
 
3.2.8 Depression and anxiety 
Groups differed significantly on clinical measures of depression and anxiety, with 
patients scoring more highly than controls on both the CDSS (t(43) = 3.93, p < .001) 
and GAD-7 (t(45) = 2.58, p = .01). Means and standard deviations for these measures 
are shown in Table 3.2. 
 
Table 3.2. Means (and standard deviations) of depression and anxiety scores for each 
group. 
Measure Patients Controls 
CDSS 5.03 (4.02) 1.80 (1.95) 





On the CDSS, 15 patients scored above the cut-off of 6, and 15 scored below. In the 
control group, 2 participants scored above the cut-off, and 25 scored below. This 
indicated that clinical depression may have been present in 50% of the patient group 
and 7% of the control group. On the GAD-7, 14 patients scored above the cut-off of 8, 
and 16 scored below. In the control group, 6 participants scored above the cut-off, and 
21 scored below. This indicated that clinical anxiety may have been present in 47% of 
the patients and 22% of the controls. 
 
3.3 The relationship between self-reported hopelessness and positive 
future thinking 
3.3.1 Group differences in self-reported hopelessness 
An independent samples t-test was carried out in order to ascertain whether group 
differences existed in self-reported hopelessness that may have the potential to 
produce spurious correlations between future-directed thinking and BHS score. The 
results revealed a significant group difference in BHS score (t(51.9) = 2.47, p = .017), 
with patients (M = 2.29, SD = 1.30) reporting greater hopelessness than controls (M = 
1.56, SD = 0.91). This indicated that any correlations observed between BHS and 





3.3.2 The relationship between self-reported hopelessness and future-
directed thinking 
Bivariate correlations were carried out between FTT-composite scores for each 
valence2 and CDSS, GAD-7 and BHS. FTT-composite was used as it incorporates all 
of the aspects of future-directed thinking captured by the FTT. The results are 
displayed in Table 3.3, which shows that there was a significant negative correlation 
between PFT-composite and both CDSS and BHS scores. 
 
Table 3.3. Bivariate correlations between FTT variables and depression, anxiety and self-





composite CDSS GAD-7 BHS 
PFT-composite - .25 -.32 -.25 -.50 
 
p = .062 p = .016 p = .063 p < .001 
NFT-composite - .09 .18 .19 
 
 
p = .489 p = .193 p = .163 
CDSS 
  
- .82 .62 
   
p < .001 p < .001 
GAD-7  
   
- .55 
    
p < .001 
 
                                                 
2 For ease of reference, for the remainder of this chapter FTT-composite scores for positively- 





These results indicated that as PFT increased, depression and self-reported 
hopelessness both decreased. No significant correlations were found between NFT-
composite and BHS. Strong positive correlations were also demonstrated between all 
three of the CDSS, GAD-7 and BHS. 
 
The correlation analysis between PFT-composite and BHS was repeated with each 
group separately, to rule out the possibility that the correlation observed was an 
artefact of the group difference already demonstrated. The results showed that the 
correlation was significant in both groups, demonstrating a reliable association 
between these variables. The data are shown in Table 3.4.  
 
Table 3.4. Bivariate correlations between PFT-composite and self-reported hopelessness, 
separated by group. 
Variable r p 
BHS   
Patients -.39 .032 
Controls -.58  .003 
 
Based on the results of the correlation analysis, a hierarchical linear regression 
analysis was performed in order to explore further the relationships between 
depression, positive future thinking, and self-reported hopelessness. A hierarchical 
regression was carried out in order to investigate whether PFT-composite could 
predict BHS score over and above the predictive ability of the CDSS. CDSS was 
entered into the regression model first followed by PFT-composite at Step 2. The 




p < .001) indicating that CDSS was significantly associated with BHS score: as 
depression rose, so did self-reported hopelessness. The model was also significant 
after the addition of PFT-composite (F(2,54) = 25.55, p < .001) and the change in the 
model was significant (F(1,54) = 10.35, p = .002). Both CDSS and PFT-composite 
contributed significantly to the final model, as shown in Table 3.5. These results 
indicate that across groups, a deficit in PFT was associated with self-reported 
hopelessness, over and above its association with depression. 
 












CDSS 0.17 0.03 .52 < .001 
PFT-composite < -0.01 < 0.01 -.33 .002 






3.4 Future-directed thinking in individuals with first episode psychosis 
and community controls 
As this was an exploratory study in a new population, group differences in future-
directed thinking were tested for using both FTT-number (the number of items 
generated on the FTT) and FTT-composite (incorporating likelihood and feelings 
ratings as well as number of items generated). Groups were compared on positively-
and negatively-valenced trials in each of the three time periods using a 2 (Group) × 3 
(Period) × 2 (Valence) mixed-model ANOVA. An analysis of covariance (ANCOVA) 
was also performed to investigate the effect of covarying for FAS score on these 
results. The Huynh-Feldt value of F was used when sphericity could not be assumed, 
and separate variance estimates were used in t-tests  when  Levene’s  test  indicated  
unequal variances. Each analysis is described in turn below. 
 
3.4.1 Group differences in the number of events generated, FTT-number 
The means and standard deviations of FTT-number for group, period and valence are 
shown in Table 3.6. 
 
Table 3.6. Means (and standard deviations) of FTT-number by group, period and valence. 
 
Positive condition Negative condition 
Time period Patients Controls Patients Controls 
1 week 5.23 (2.36) 7.07 (3.10) 3.33 (1.54) 4.81 (1.62) 
1 year 4.97 (2.13) 7.37 (3.24) 3.07 (1.51) 4.67 (1.64) 
5-10 years 4.97 (1.94) 6.70 (2.40) 3.77 (2.06) 5.11 (1.67) 





The Group × Period × Valence mixed-model ANOVA for the number of items 
generated on each trial of the FTT revealed a significant main effect of group 
(F(1,55) = 17.67, p < .001), reflecting the fact that patients (M = 4.22, SD = 1.45) 
generated fewer items overall than controls (M = 5.96, SD = 1.67). A significant main 
effect of valence was also apparent (F(1,55) = 66.36, p < .001), with participants from 
both groups finding it more difficult to generate items in the negatively-valenced trials 
(M = 4.09, SD = 1.51) than in the positively-valenced trials (M = 6.00, SD = 2.37) 
when time periods were combined. There was no main effect of period 
(F(2,110) = 0.19, p = .827). 
 
The analysis revealed a significant Period × Valence interaction across groups 
(F(2,110) = 3.21, p = .044). There were no significant Group × Period 
(F(2,110) = 0.68, p = .510) or Group × Valence (F(1,55) = 1.20, p = .278) 
interactions, nor was there a significant three-way Group × Period × Valence 
interaction (F(2,110) = 0.22, p = .802).  
 
Visual inspection of the data (see Figure 3.1) suggested that the source of the Period × 
Valence interaction may be differences in scores on the negatively-valenced trials. 
Therefore, repeated measures ANOVAs were conducted to compare the number of 
items generated at each time period for each valence separately. This analysis 
revealed no significant effect of period in the positively-valenced trials 
(F(2,112) = 0.70, p = .500), but an effect of period approaching significance was 
indicated in the negatively-valenced trials (F(2,112) = 3.03, p = .052). Post hoc t-tests 




in the 5-10 year negative trial (M = 4.40, SD = 1.99) over that generated in the 1 year 
negative trial (M = 3.82, SD = 1.75; t(56) = 2.59, p = .012). 
 
 
Figure 3.1. Mean FTT-number in each valence, plotted against time period. Error bars 
represent standard error of the mean. 
 
In summary, the results of this analysis indicated that patient participants found it 
harder to generate events of any kind in their future than did controls. It was also 
more difficult for people in either group to think of negative expected events in their 
future than to think of positive expected events. Finally, the results indicated that the 
number of future events generated for any given time period may be dependent on the 


























significance, further analysis showed that it may be easier for people to think of 
negative future events expected in the next 5-10 years than in the next 1 year. 
 
In order to investigate the effect of verbal fluency on the analysis of FTT-number 
described above an ANCOVA was performed with FAS score as the covariate. The 
results of the original ANOVA were upheld, except in the case of the main effect 
valence, which was no longer significant (F(1,54) = 0.01, p = .913), and the Period × 
Valence interaction, which was also eliminated (F(2,110) = 1.91, p = .153). The main 
effect of group remained significant (F(1,54) = 33.90, p < .001). 
 
3.4.2 Group differences in FTT-composite score 
The means and standard deviations of FTT-number for group, period and valence are 
shown in Table 3.7. 
 
Table 3.7. Means (and standard deviations) for FTT-composite by group, period and 
valence. 
 
Positive condition Negative condition 
Time period Patients Controls Patients Controls 
1 week 67.24 (40.82) 84.46 (49.18) 23.41 (17.10) 25.76 (16.29) 
1 year 60.29 (35.31) 99.05 (58.82) 22.74 (17.29) 32.94 (18.74) 
5-10 years 69.14 (39.26) 86.45 (44.39) 25.62 (19.95) 36.74 (22.80) 






The Group × Period × Valence mixed-model ANOVA for FTT-composite score 
revealed a significant main effect of group (F(1,55) = 7.43, p = .009), reflecting the 
fact that patients (M = 44.74, SD = 20.24) had lower composite scores overall than 
controls (M = 61.60, SD = 25.92). A significant main effect of valence was also 
apparent (F(1,55) = 92.94, p < .001), with participants from both groups having lower 
mean composite scores in the negatively-valenced trials (M = 27.49, SD = 14.82) than 
in the positively-valenced trials (M = 77.49, SD = 41.91), regardless of period. There 
was no main effect of period (F(2,110) = 1.25, p = .292). 
 
The analysis revealed a significant Group × Period interaction across valences 
(F(2,110) = 3.39, p = .037). There were no significant Group × Valence 
(F(1,55) = 2.55, p = .116) or Period × Valence (F(2,110) = 0.53, p = .572) 
interactions, nor was there a significant three-way Group × Period × Valence 
interaction (F(2,110) = 2.05, p = .134). 
 
Post hoc t-tests revealed that the source of the Group × Period interaction was 
variation in the size of group differences across time periods; Figure 3.2 shows the 
data visually. Patients were statistically similar to controls in their composite scores 
for the 1 week trials (t(55) = 1.41, p = .164), but significantly different from controls 
in their composite scores for the 1 year trials (t(55) = 3.70, p < .001) and the 5-10 year 
trials (t(55) = 2.15, p = .036). Patients had lower composite scores for the 1 year trials 
(M = 41.51, SD = 20.33) and the 5-10 year trials (M = 47.38, SD = 23.87) than 
controls for either trial (1 year M = 66.54, SD = 30.21; 5-10 year M = 62.74, 






Figure 3.2. Mean FTT-composite score for each group, plotted against time period. 
Error bars represent standard error of the mean. 
 
In summary, the results of this analysis indicate that the first episode psychosis 
sample had lower future expectancies for any valence than controls, as measured by a 
composite score that incorporated likelihood and feeling ratings as well as number of 
events generated. They also had lower future expectancies for both valences for the 
next year and 5-10 years than controls. Participants in both groups had higher positive 





























In order to investigate the effect of verbal fluency on the analysis of FTT-composite 
scores an ANCOVA was performed that was identical to the ANOVA described 
above except for the inclusion of FAS score as a covariate. The results of the original 
ANOVA were upheld, except in the case of the main effects of group (F(1,54) = 1.78, 
p = .188) and valence (F(1,54) = 0.59, p = .445), which were not maintained after 
covarying for FAS score. The Group × Period interaction remained significant 






3.5 Content of future-directed thinking in first episode psychosis and 
community controls 
As the data were not normally distributed, it was not appropriate to perform a mixed-
model ANOVA for the analysis of the content of future thinking in the groups as was 
done for other FTT variables. Instead, Mann-Whitney tests were used to compare 
groups on the number of items generated in each category for each valence. Time 
periods were combined to reduce the number of multiple comparisons and control 
Type I error. The tests revealed significant group differences in the number of events 
generated in the Relations with Other People and Personal Development and 
Understanding categories, in both positively- and negatively-valenced trials (see 
Table 3.8). Specifically, patients generated significantly fewer items than controls on 
both of these categories. After Bonferroni correction for ten tests, which required that 
p-values were less than .005 for a significant result, group differences remained 













Table 3.8. Mean number of items in each FTT category by valence and group, with 
summary statistics. 
 Mean number of events    
Category Patient Control U z p 
Positive valence 
Physical and material wellbeing 2.30 0.42 337.5 -1.10 .273 
Relations with other people 3.80 0.63 265.5 -2.25 .024 
Social, community and civic activities 0.30 0.09 465.5 1.41 .159 
Personal development and fulfilment 3.50 0.46 240.5 -2.66 .008 
Activities 5.27 1.09 329.5 -1.21 .226 
Negative valence 
Physical and material wellbeing 3.40 0.42 334.0 -1.15 .251 
Relations with other people 2.30 0.45 215.5 -3.06 .002 
Social, community and civic activities 0.17 0.19 315.0 -1.87 .061 
Personal development and fulfilment 2.27 0.36 222.0 -2.97 .003 
Activities 2.00 0.35 434.5 .48 .630 






3.6 The relationship between future-directed thinking and suicidal 
ideation in individuals with first episode psychosis 
The demographic profile of the groups scoring zero and non-zero on the SSI are 
shown in Table 3.9. Groups did not differ significantly on age (t(28) = -0.07, 
p = .943), gender (p = .236, FET), education (U = 118.5, z = .28, p = .790), 
employment status (p = .694, FET), ethnic group (p = .147, FET), or first language 





















Table 3.9. Demographic summary of the groups scoring zero and non-zero on the SSI. 
 SSI score 
Demographic Zeroa Non-zerob 
Age, mean (SD) 26.5 (4.9) 26.6 (4.6) 
Age range 20-35 19-35 
Gender, n (%)   
Male 8 (57) 13 (81) 
Female   6 (43)   3 (19) 
Educational level, median (range)     (0-6)     (0-6) 
Employment, n (%)   
Employed   5 (36) 4 (25) 
Not employed 9 (64) 12 (75) 
Ethnic group, n (%) 
  White 7 (50) 12 (75) 
Mixed / Multiple ethnic groups 1 (7) 1 (6) 
Asian / Asian British 2 (14) 3 (19) 
Black / African / Caribbean / Black British 4 (29) 0 (0) 
Other ethnic group 0 (0) 0 (0) 
First language, n (%)   
English 12 (86) 10 (62) 
Not English 2 (14) 6 (38) 
Verbal fluency total score, mean (SD) 26.7 (10.7) 24.3 (8.9) 





The relationship between future thinking and suicide ideation was investigated using 
hierarchical logistic regression. Hierarchical regression was chosen over standard 
regression in order to establish whether PFT  and NFT could predict SSI score (zero 
or non-zero) over and above the effects of depression, anxiety, and self-reported 
hopelessness. CDSS, GAD-7 and BHS scores were entered into the model first, 
followed at Step 2 by FTT-composite scores for each valence, combined across 
periods. The dependent variable was SSI score. The full model is shown in Table 
3.10. 
 
Table 3.10. Summary of hierarchical logistic regression analysis for variables predicting SSI 
score. 




CDSS total score -0.13 0.21 0.88 .544 
GAD-7 total score 0.08 0.11 1.08 .476 




CDSS total score -0.08 0.22 0.92 .716 
GAD-7 total score 0.04 0.11 1.04 .733 
BHS total score 0.33 0.53 1.39 .531 
PFT-composite -0.01 0.01 0.99 .344 
NFT-composite  0.03 0.02 1.03 .087 






The overall model at Step 1 was non-significant  (χ2(2) = 5.86, p = .119), suggesting 
that CDSS, GAD-7 and BHS scores did not significantly predict SSI score. None of 
the variables contributed significantly to the model, though BHS showed a trend 
towards significance (see Table 3.10). The addition of PFT-composite and NFT-
composite into the model did not produce significant change in the predictive ability 
of  the  model  (χ2(2) = 3.64, p = .162), but the model overall showed a trend towards 
significance (χ2(2) = 9.50, p = .091). NFT-composite showed a trend towards a 
significant contribution to the model (Wald(1) = 2.93, B = .03, SE = .02, p = .087), 
whereas PFT-composite did not. 
 
The hierarchical logistic regression analysis suggested that FTT variables, especially 
NFT-composite, may significantly predict SSI score, but that the addition of clinical 
and hopelessness variables in Step 1, whilst not predictive of SSI score, may have 
weakened this effect through not themselves being related to SSI but removing some 
variability in SSI score that would otherwise be predicted by the FTT variables. 
Moreover, the inclusion of the clinical and hopelessness variables reduced the 
statistical power of the FTT variables to predict SSI score without adding predictive 
ability to the model. Therefore the relationship between SSI score and FTT variables 
alone was investigated using  a simple logistic regression with PFT-composite and 
NFT-composite as independent variables, and SSI score as the dependent variable. 
















PFT-composite -0.01 0.01 0.99 .089 
NFT-composite 0.03 0.01 1.03 .017 




Figure 3.3. Mean FTT-composite score for each valence, plotted against SSI score. 






























The  overall  regression  model  was  significant  (χ2(2) = 8.97, p = .011). There was a 
significant relationship between SSI and NFT-composite (Wald(1) = 5.68, B = .03, 
SE = .01, p = .017), with increased NFT-composite predicting SSI score greater than 
1. The association between PFT-composite and SSI tended towards significance 
(Wald(1) = 2.89, B = -.01, SE = .01, p = .089), with reduced PFT-composite tending 
to predict a SSI score greater than 1. 
 
This result shows that FTT variables, in particular increased NFT, were associated 
with SSI scores greater than zero. In combination with the results of the hierarchical 
regression, it can be concluded that the clinical measures were not uniquely associated 
with SSI, but a significant amount of variance in SSI was uniquely explained by 






3.7 The relationship between future-directed thinking and negative 
symptoms in individuals with first episode psychosis 
The relationship between future thinking and the negative symptoms of psychosis, as 
measured by the SANS, was first investigated using bivariate correlations. The results 
are shown in Table 3.12. 
 
Table 3.12. Bivariate correlations between negative symptoms and depression, anxiety, 









CDSS - .82 .62 -.32 .09 .33 
  
p < .001 p < .001 p = .016 p = .489 p = .078 
GAD-7 
 
- .55 -.25 .18 .38 
   
p < .001 p = .063 p = .193 p = .040 
BHS 
  
- -.50 .19 .43 
    
p < .001 p = .163 p = .017 
PFT-composite 
   
- .25 -.55 
     
p = .062 p = .002 
NFT-composite 
    
- -.12 
      









These correlations indicate that SANS was positively correlated with GAD-7 and 
BHS, and strongly negatively correlated with PFT-composite score. Other 
correlations shown in Table 3.12 have been described previously. Based on these 
results, the relationships between SANS, GAD-7, BHS and PFT-composite were 
investigated further using hierarchical linear regression. Hierarchical regression was 
chosen over standard regression in order to establish whether PFT could predict 
SANS score over and above the effects of anxiety and self-reported hopelessness. 
GAD-7 and BHS scores were entered into the model first, followed at Step 2 by PFT-
composite for all periods combined. The dependent variable was SANS score. The 
full model is shown in Table 3.13. 
 
Table 3.13. Summary of hierarchical linear regression analysis for variables predicting 
SANS score. 




GAD-7 total score 0.26 0.25 .19 .374 




GAD-7 total score 0.16 0.23 .14 .479 
BHS total score 1.22 1.32 .18 .365 
PFT-composite -0.04 0.02 -.43 .018 
Note. R2 =  .21  for  Step  1.  ΔR2 = .16 (p = .018). 
 
The overall model was significant at Step 1 (F(2,27) = 3.63, p = .04), though neither 




overall model was also significant at Step 2 (F(3,26) = 5.01, p = .007) and the change 
in the model was significant (see Table 3.13), showing that the addition of FTT 
variables into the model improved its fit with the dependent variable SANS score. The 
overall model explained 29% of the variance in SANS score. 
 
These results indicate that within the patient group, positive future thinking was a 
significant predictor of negative symptom severity, over and above its relationship 





 Chapter  4 
Discussion 
4.1 Summary of results 
The first aim of the current study was to replicate previous work by demonstrating a 
relationship between self-reported hopelessness and reduced PFT across all 
participants. Consistent with Hypothesis 1, the results showed that reduced PFT was 
indeed associated with self-reported hopelessness, and that this was independent of 
their mutual relationship with depression. As hypothesised, negative future-directed 
thinking was not associated with self-reported hopelessness. 
 
The second aim of this work was to investigate group differences in future-directed 
thinking between individuals with first episode psychosis and matched community 
controls. The results upheld Hypothesis 2 by showing that participants in the 
psychosis group generated significantly fewer positive future events than controls, 
and had lower scores on the composite variable involving number, feelings and 
likelihood. The same was true in the negatively-valenced trials, which was consistent 
with the second part of Hypothesis 2: that NFT would not be increased in patients 
relative to controls. There was also an interaction involving time period on the overall 
composite score: individuals with psychosis had lower future expectancies for the 
next 1 year and the next 5-10 years compared to controls, but the groups did not differ 
in their future-directed thinking for the next 1 week. Investigation of the second aim 
of this study also revealed consistently lower NFT than PFT across groups, and an 
interaction between valence and period that showed that participants were able to 




was no difference in the number of positive events generated at different time periods. 
The latter two results will not be discussed further, as they were not related to the 
main hypotheses of the study. 
 
Aim 3 of the study was to characterise the content of future-oriented cognitions in 
psychosis in comparison with those of community controls. The results of the content 
analysis showed that individuals with psychosis generated significantly fewer events 
concerning relations with other people, and concerning personal development and 
fulfilment. Individuals with psychosis did not generate more items than controls in 
any of the categories.  
 
Aim 4 was to examine the association between future-directed thinking and suicide 
ideation in individuals with first episode psychosis. The results were inconsistent with 
Hypothesis 3, which predicted a relationship with PFT but not with NFT. The results 
showed that increased NFT was associated with suicide ideation in the psychosis 
group, but that reduced PFT was only weakly associated with suicide ideation. 
 
The fifth aim of the study was to investigate whether specific aspects of future-
directed thinking were associated with negative symptoms in individuals with first 
episode psychosis. Hypothesis 4 predicted that decreased PFT would be associated 
with increased severity of negative symptoms, and this was supported by the results. 






4.2 The relationship between self-reported hopelessness and positive 
future thinking 
The current study aimed to investigate the relationship between PFT and self-reported 
hopelessness in individuals with first episode psychosis and matched controls. The 
results showed that across the whole sample, and in the psychosis group alone, PFT 
was significantly negatively correlated with self-reported hopelessness, indicating that 
as PFT decreased self-reported hopelessness increased. Moreover, this relationship 
was maintained when depression was added into the regression model before PFT, 
demonstrating that it was independent of any concurrent relationship with depression. 
These results support Hypothesis 1 and are consistent with previous research, which 
has found a reliable relationship between reduced PFT and hopelessness in a range of 
patient groups such as people who have recently attempted suicide (Hunter & 
O'Connor, 2003; MacLeod, Pankhania, et al., 1997; MacLeod et al., 1993), including 
older people (Conaghan & Davidson, 2002), and people with depression (MacLeod & 
Byrne, 1996). 
 
This is the first time that this relationship has been demonstrated in individuals with 
psychosis, and the results indicate that the PFT may be used as an indicator of 
hopelessness in this patient group. The FTT is quick to administer, and is an objective 
measure that may be less susceptible to the effects of social desirability than self-
report measures such as the BHS (Ivanoff & Jang, 1991; Linehan & Nielsen, 1981). 
Previous research has also shown that it is a better predictor of future suicidal ideation 
than BHS (O'Connor et al., 2008). Therefore it may be a useful tool in the assessment 




improvement of hopelessness in psychosis, in the form of an intervention to improve 
PFT. Previous work has shown that this approach can be effective, and this is 
discussed in detail in Section 4.9.1. Given the close association between hopelessness 
and risk for suicide and self-harm in a range of patient groups including psychosis, 
interventions to improve PFT could be an important clinical route for the reduction of 
suicide risk in first episode psychosis. 
 
4.3 Future-directed thinking in individuals with first episode psychosis 
and community controls 
This study aimed to utilise the FTT to compare the future-directed thinking of 
individuals in the early stages of psychosis with that of matched controls. The FTT 
has been used in a range of patient groups, including people with depression, anxiety, 
eating disorders, multiple sclerosis, tinnitus and recent DSH, but in people with 
psychosis it has been used only once before, and not in comparison with controls 
(Black, 2013). Studies of thinking about the future in psychosis have tended to focus 
on scene construction, which is the ability to imagine possible future events in detail, 
in response to cues (D'Argembeau et al., 2008; de Oliveira et al., 2009; Raffard et al., 
2010; Raffard et al., 2013). These scenes are then rated for qualities such as 
specificity, spatial coherence, numbers of objects, presence of people and animals, 
and emotional content. To my knowledge, no study has compared the ability of 






A main effect of group was demonstrated in the analysis of both FTT-number and 
FTT-composite scores, with patients finding it more difficult to think of events of any 
kind in their future, whether positive or negative. There was no interaction between 
the number of events generated by patients and controls and the valence of the events. 
In short, patients had a globally reduced capacity to think about future events of any 
kind. These results were consistent with Hypothesis 2, which asserted that individuals 
with first episode psychosis would display reduced PFT in the absence of an increase 
in NFT. However, whilst a reduction in NFT was not inconsistent with the hypothesis, 
it was unexpected. In the existing literature on future-directed thinking in individuals 
with a recent episode of DSH or who are depressed, PFT is consistently reduced 
whilst NFT is unchanged. As individuals with psychosis are known to be at increased 
risk of DSH, and in the current sample half had depression scores consistent with the 
presence of a major depressive episode, it was expected that this pattern would be 
replicated. Moreover, the current psychosis sample also reported significantly higher 
levels of hopelessness, which is also associated with reduced PFT and intact NFT. 
 
Previous literature investigating the quality of future-directed thinking specifically in 
psychosis would initially appear to be consistent with the global impairment in future-
directed thinking observed in the current study, as reductions in the quality and 
specificity of details generated about future events were observed in comparison with 
controls in three separate studies (D'Argembeau et al., 2008; de Oliveira et al., 2009; 
Raffard et al., 2010). However, these studies did not distinguish between valences of 
events, therefore it was not possible to conclude whether the observed reductions 
were due to an impairment in PFT, NFT, or both. In the only study to report results 




fewer sensory details, contextual details and self- and other-referential details for 
events of both valences, but showed a greater reduction in the specificity of the events 
they generated for positive events relative to negative events, compared with controls. 
Therefore the results of the Raffard et al. 2013 study partly support the current results 
by demonstrating a reduced ability to think of certain kinds of details about future 
events of both valences, but are also congruent with previous literature in other patient 
groups, through demonstrating that specificity of PFT may be more impaired than 
NFT. It should be remembered that these psychosis-specific studies did not measure 
the maximum number of events that could be generated, but the characteristics of 
descriptions given in response to cues. The following discussion considers why 
psychosis may be associated with a reduced capacity to think about the future 
generally. It is approached in terms of three broad themes: psychological and 
psychiatric, neuropsychological, and social. 
 
4.3.1 Psychological and psychiatric considerations 
Participants in the psychosis group may have found it more difficult to generate future 
events of either valence because of the potential experience of positive symptoms 
during the task. Symptoms such as auditory hallucinations in some participants may 
have distracted participants from the task of generating events and resulted in a poorer 
performance. Auditory hallucinations may have also contributed directly to an 
inability to think of events in the future, particularly positive ones, since they are often 
highly derogatory or critical in nature and challenge the individual’s  self-esteem. 
These types of messages may directly influence future-directed thinking by creating 
or maintaining a negative view of the self and a sense of reduced prospects for the 




population from those in previous studies employing the FTT, for example depressed 
and suicidal groups, and may explain why the patterns of future-directed thinking 
demonstrated here are not in line with those seen in other groups. It was not feasible 
in this study to measure positive symptoms at the time of testing, but this is something 
that future work might consider in order to explore their relationship with future-
directed thinking.  
 
The work of Birchwood and others on beliefs about illness offers an another 
explanation for reduced future-directed thinking in psychosis. The Personal Beliefs 
about Illness Questionnaire (PBIQ) has been used to study perceptions of psychotic 
illness by sufferers. Domains covered in the questionnaire include beliefs about 
entrapment, loss, social marginalisation, shame, and control (Birchwood, Jackson, 
Brunet, Holden, & Barton, 2012). Studies using the PBIQ show that individuals with 
psychosis have beliefs about their illness that include loss of autonomy, loss of social 
role, feelings of entrapment, and an expectation that they will occupy lower status 
roles in the future (Iqbal, Birchwood, Chadwick, & Trower, 2000; Rooke & 
Birchwood, 1998). Such beliefs and internalised messages about what it means to 
have psychosis could result in individuals having difficulty imagining what the future 
will be like, and potentially feeling like they have no future. Consistent with this 
hypothesis is the work of  R. G. White et al. (2007), which showed an association 
between negative beliefs about illness and hopelessness in schizophrenia. 
Alternatively, negative beliefs about illness may contribute to a motivational 
explanation for reduced future-directed thinking, namely, a reluctance to think about 
the future because of a wish to avoid negative thoughts about what their illness might 




about the possibility of relapse, loss of employment or education, loss of status and 
autonomy, or the breakdown of relationships. Disengaging from the future to achieve 
protection from such thoughts would have the unwanted side effect of preventing PFT 
as well as NFT, resulting in an overall reduction in future-directed thinking.  
 
4.3.2 Neuropsychological considerations 
The general deficit in future-directed thinking observed in the psychosis group may be 
a result of their reduced verbal fluency, since the FTT is based on tests of verbal 
fluency (MacLeod et al., 1993). In support of this explanation, both PFT and NFT 
were found to be highly correlated with the FAS test. This is contrary to the work of 
D'Argembeau et al. (2008), who found that verbal fluency was not associated with 
future thinking, however, the focus in their study was on specificity, rather than 
number of items generated, which could explain the discrepancy. Performance on the 
FAS in previous research has not tended to differ between groups of controls and 
samples of individuals with DSH (MacLeod, Pankhania, et al., 1997; MacLeod, Tata, 
Kentish, & Jacobsen, 1997; O'Connor, Connery, & Cheyne, 2000) or with depression 
or anxiety (MacLeod & Salaminiou, 2001). However, cognitive deficits in psychosis 
are well established (Heinrichs & Zakzanis, 1998) and therefore this result is not 
wholly surprising. It is important, then, that controlling for total FAS score in the 
analysis of the number of items generated left the main effect of group intact, 
suggesting that there was a residual deficit in future-directed thinking that was 
independent of verbal fluency. Thus, it seemed that an inherent difficulty in 
generating words was not the sole reason for patients’  difficulties  in  thinking  of future 
events, though due to its high correlation with scores on both positively- and 




for FAS score did eliminate the main effect of group on the composite scores of the 
FTT, which combined number of events generated with mean likelihood and feelings 
ratings for each. This was a surprising result because it was not expected that FAS 
score would be related to any variables other than number of items. One potential 
explanation for this is the fact that the covariance approach is unsuitable for use with 
groups that differ significantly on the covariate; this is discussed further in the 
Limitations section. 
 
Deficits in memory may also play a crucial part in the reduction in future thinking 
observed in this study. The generation of events that might happen to oneself and the 
clarity with which a person can imagine these events has been shown to be dependent 
on autobiographical memory: the ability to recall events from the past (Schacter, 
Addis, & Buckner, 2007). This is supported by neurobiological studies showing that 
similar neural processes are involved in both mental tasks (Schacter & Addis, 2007). 
This link has been demonstrated in people who are suicidal (Williams et al., 1996), 
with the memories and future events generated by suicidal participants being more 
general in nature. More recently it has been shown that people with psychosis have 
impaired and over-general autobiographical memory in the absence of mood 
disturbance (de Oliveira et al., 2009; Raffard et al., 2010; Wood, Brewin, & McLeod, 
2006), and that this is indeed associated with an impairment in ability to generate 
events in the future (D'Argembeau et al., 2008). Thus a reduction in autobiographical 
memory in individuals with first episode psychosis may explain their impaired ability 
to generate future events. It is important to note that as described previously, 
imageability tasks require the generation and elaboration of limited numbers of events 




Nevertheless, both tasks require consideration of the future, therefore 
autobiographical memory is likely to have a bearing on both. 
 
It is well established that individuals with schizophrenia exhibit structural and 
functional brain differences in comparison with matched controls (Gur, Keshavan, & 
Lawrie, 2007; McCarley et al., 1999; Shenton, Dickey, Frumin, & McCarley, 2001; 
Steen, Mull, McClure, Hamer, & Lieberman, 2006), and that these are associated with 
a variety of cognitive deficits (Driesen et al., 2008; Honey et al., 2005; Potkin et al., 
2009; Volz et al., 1999). Thus it is possible that the deficit in future-directed thinking 
observed in the current study is underpinned by structural and functional 
abnormalities, perhaps similar to those that are seen to be associated with deficits in 
verbal fluency such as reduced  frontal  activation,  more  bilateral  activation  in  Broca’s  
area, and reduced anterior cingulate cortical activation (Boksman et al., 2005; Curtis 
et al., 1998; Fu et al., 2005; Weiss et al., 2004). 
 
A detailed discussion of the neuroanatomy of cognitive deficits in the psychotic 
disorders is beyond the scope of this thesis, but one study (Eack, George, Prasad, & 
Keshavan, 2008) is notable because of its specific consideration of a phenomenon 
related to future-directed thinking: foresight. Foresight concerns the ability to foresee 
the  consequences  of  one’s  actions,  and is therefore arguably similar to the ability to 
predict events  in  one’s  future.  Therefore,  it  may  give  an  indication  of  the  kinds  of  
neuroanatomical areas that may contribute to deficits in future-directed thinking. Eack 
et al. investigated individuals in the early stages of schizophrenia, and found that 
better foresight was most strongly associated with an increased density of grey matter 




foresight may be associated with reductions in grey matter in this region. However, 
this study did not include a comparison group, therefore it is not possible to conclude 
that the reduced foresight observed in the study sample was associated with changes 
in this area of the brain. A repetition of this study with a comparison group would 
help to clarify this issue. 
 
4.3.3 Social considerations 
Reduced future-directed thinking in psychosis may be associated with the impact of 
being in the care of severe mental health services. A high level of support is provided 
by early intervention teams, including involvement from a care coordinator, a 
psychiatrist, possibly a psychologist, and frequently a support or vocational worker. 
Whilst demonstrably helpful to recovery, it is possible that this level of support and 
intervention  contributes  to  a  reduction  in  individuals’  sense  of  agency  over  their  
future. The timing of the onset of psychosis is also a potential contributing factor. 
Psychosis tends to occur in late adolescence and the early twenties: a time in an 
individual’s  life  when  they  are  beginning  to  establish  their  independence  and  think  
about their hopes for the future. They may have been developing ideas about going to 
university or getting a job, having a career, and moving out of home. The onset of 
psychosis is highly disruptive to the lives of sufferers, and is likely to produce a 
feeling that these plans must be put on hold until the individual has recovered from 
the illness. This is supported by the current results, which show that the group 
difference between the number of events generated by patients and controls was larger 
for the period of 1 year than for the period of 5-10 years. Patients may feel that the 
next 12 months is an uncertain time in the course of their recovery, and may wish to 




hopeful, as patients may feel they can reasonably expect full recovery within that 
time, and a return to typical activities and life events (such as marriage, children, 
having a job). 
 
Stigma provides a further potential explanation for reduced future-directed thinking in 
psychosis, in particular PFT. Stigma is defined by the Oxford English Dictionary as 
“a mark  of  disgrace  or  infamy;;  a  sign  of  severe  censure  or  condemnation”  (2014). 
More sophisticated definitions of the stigma concept as applied to human experience 
require the convergence of several factors for the presence of stigma. For example, in 
Link and  Phelan’s  2001 conceptualisation stigma  exists  when  “elements  of  labelling,  
stereotyping, separation, status loss, and discrimination co-occur in a power situation 
that  allows  the  components  of  stigma  to  unfold.” (Link & Phelan, 2001, p. 367). 
Stigma in mental health has been shown to result in the loss of opportunities including 
for employment, the experience of social exclusion, increased poverty and 
homelessness, poor living conditions, poorer health outcomes, and verbal abuse 
(Angermeyer, Beck, Dietrich, & Holzinger, 2004; Kelly, 2005). Stigma has also been 
shown to be predictive of future low self-esteem in people diagnosed with mental 
health disorders (41% of which were psychotic disorders; Link, Struening, Neese-
Todd, Asmussen, & Phelan, 2001) and poorer overall recovery prospects. 
 
With the stigma associated with mental illness being evident in many aspects of life 
(Lasalvia et al., 2014) it is highly likely that the expectation of stigma and 
discrimination  from  others  may  influence  sufferers’  views about their future. A study 
of individuals with psychosis by Angermeyer et al. (2004) demonstrated that 




regarding access to work, and suggested that patients may avoid situations in which 
they expect to experience stigma. For example, they may avoid applying for jobs on 
the basis that they may experience stigma or discrimination during the process. 
Recent work supports this, showing that anticipated discrimination in individuals with 
psychosis leads individuals to avoid seeking close relationships and looking for work 
(Lasalvia et al., 2014). The experience of stigma may also result in these attitudes 
being internalised and impacting on the way that individuals with psychosis perceive 
themselves and their future. One study (Acosta, Aguilar, Cejas, & Gracia, 2013) 
showed that individuals with schizophrenia felt their illness was a judgement on them, 
and that this showed strong associations with hopelessness. This work supports the 
hypothesis that stigma is linked with hopelessness, and therefore could be responsible 
for the decrease in future-directed thinking observed in this study. 
 
Group differences in employment status in this study approached significance, and it 
is possible that this contributed to the observed group differences in future-directed 
thinking. As well as financial reward, employment provides a social identity, status, 
and a sense of involvement, and has been shown to correlate with positive outcomes 
such as improved social functioning, lower symptom levels, better quality of life and 
increased self-esteem in individuals with schizophrenia (Marwaha & Johnson, 2004). 
Conversely, unemployment is linked with social exclusion in serious mental illness 
(Boardman, Grove, Perkins, & Shepherd, 2003). The concepts associated with a lack 
of employment, then, are closely related to elements of stigma such as loss of status 
and separation. If, as argued above, stigma is linked with future-directed thinking, this 
would indicate that unemployment may contribute to a reduced ability to imagine the 





In summary, a wide variety of factors may be responsible for the observed global 
reduction in future-directed thinking in individuals with first episode psychosis. These 
include psychological reasons such as beliefs about illness or motivational factors, 
psychiatric reasons such as the direct effects of symptoms, neuropsychological 
disturbances including general and specific cognitive impairments, and social factors 
such as the experience of stigma and the effects of unemployment. The clinical 
implications of these findings and areas for future research are discussed further in 
Section 4.9. 
 
4.4 Content of future-directed thinking in first episode psychosis and 
community controls 
There were no a priori hypotheses about differences between patients and controls on 
the content of their future thinking, so this was a purely exploratory aspect of the 
study. Previous work has shown a tendency for people with bulimia to show an 
increase in intrapersonal- and health-related thoughts in both positive and negative 
conditions (Godley et al., 2001), and a tendency for people with anorexia to show an 
increase in intrapersonal- and health-related thoughts in the positive condition, and 
achievement / failure-related future-directed cognitions in the negative conditions 
(Godley et al., 2001). Another study has examined the content of future-directed 
thinking in individuals with Multiple Sclerosis (MS), on the basis of whether the 
items are connected with their illness or not. This study found that individuals with 
MS and depression were more likely to generate illness-related items than the MS 




directed thinking in psychosis and compare it with that of controls. Moreover, this is 
one of the first studies to employ a method of coding of future thinking based on a 
well-validated quality of life scale. 
 
This study demonstrated that patients and controls differed on the number of items 
they generated concerning relationships with other people, and concerning personal 
development and understanding. Specifically, patients generated significantly fewer 
items in each of these categories than controls. Before correction for multiple 
comparisons these results reached significance in both positively- and negatively-
valenced trials, but after correction only the group differences in negatively-valenced 
trials remained significant. However, as group differences were demonstrated in the 
same categories in both valences, this increases the confidence that the differences 
observed in the positively-valenced trials represent real effects and did not occur by 
chance. 
  
The Relations with Other People category included relations with a significant other 
or family members, having children and relations with friends. It also included 
relations with people not falling into these categories where the interaction with 
another person was the main focus of the item. A reduced ability to generate future 
events in this category may be connected with negative symptoms. Negative 
symptoms include a reduction in interest in peer and family relationships and reduced 
feelings of closeness. In the current study it was noted that individuals with psychosis 
often reported a decrease in the number of friends they had, and in some cases rifts 
with family members were described. In some individuals not only did they report 




logical that if an individual is less interested and involved in relationships with others 
then they would expect fewer events involving other people to happen to them in the 
future, whether looked forward to or otherwise. Interestingly, there was no reduction 
in the number of recreational and other activities looked forward to in patients 
compared with controls, which would be expected to associate with avolition and 
apathy. This suggests that this particular aspect of negative symptomatology may 
have been less prominent in the current sample. 
 
Reduced future-directed thinking about relationships may be a further product of 
expectations or experiences of stigma and beliefs about illness. As discussed above, 
individuals with psychosis tend to expect stigma and discrimination from others, and 
to be less likely to engage in activities (such as dating) that might expose them to 
stigmatising experiences. Specific studies have highlighted perceptions by individuals 
with psychosis that they are rejected or avoided by others (Lasalvia et al., 2014; 
Schulze & Angermeyer, 2003), which would tend to inhibit expectations of future 
experiences related to other people. Stigma and beliefs about illness also provide an 
explanation for a reduction in items generated in the Personal Development and 
Understanding category, which includes items related to education, work and 
creativity, understanding, and autonomy. As discussed above, individuals with 
psychosis perceive and experience reduced opportunities as a result of stigma, and 
may feel less inclined to pursue these in order to avoid the experience of stigma and 
discrimination. They also endorse statements consistent with a perceived reduction in 
autonomy as a result of their illness. It is little wonder, then, that work, autonomy and 






It is interesting to note that whilst the means of each of the other three categories were 
also lower in the psychosis group than in the controls, the group differences were not 
significant. This hints that the main source of reduced future thinking in individuals 
with first episode psychosis may be a reduced capacity to think about future 
relationships with other people and their future personal development and 
understanding. Therefore interventions to help improve relations with other people 
and  to  plan  for  one’s personal development and autonomy may be of particular help in 
improving future-directed thinking. It was noted that in both groups far fewer items 
were generated that coded into the Social, Community and Civic Activities category 
than any other. Since this was the category in which the non-parametric nature of the 
data was most problematic, future work may wish to adapt the coding scheme to 
incorporate items from this category into the other, larger categories. 
 
4.5 The relationship between future-directed thinking and suicidal 
ideation in individuals with first episode psychosis 
This study aimed to replicate the effect demonstrated in numerous previous studies, 
that a reduction in positive future thinking is associated with an increased risk of 
suicide. The results showed that neither variables of depression, anxiety or self-
reported hopelessness nor FTT-composite scores for either valance were associated 
with suicidal ideation when used to predict suicide ideation score together. However, 
when FTT variables alone were used to predict suicidal ideation, NFT was a unique 




tendency for decreased PFT to predict an SSI score of greater than zero, but this trend 
did not reach significance. 
 
The finding that suicide risk was not significantly associated with a reduction in PFT 
contradicted Hypothesis 3 and was unexpected, since many studies of people who are 
suicidal or engage in DSH have pointed towards this relationship (Conaghan & 
Davidson, 2002; MacLeod, Pankhania, et al., 1997; MacLeod et al., 1993; MacLeod 
et al., 1998; MacLeod et al., 2004; O'Connor et al., 2008). It was expected that the 
pattern of future-directed thinking in the psychosis group would be consistent with 
this, given the increased risk of suicide and high levels of DSH in psychosis. One 
explanation for this discrepancy is the fact that the studies in the literature have 
predominantly focused on individuals who have made a suicide attempt very recently, 
whereas in the current study, the temporal association between testing sessions and a 
suicide attempt was far weaker, and only 28% of the patients reported a history of 
suicide attempt. The detection of associations between suicide risk and future-directed 
thinking was reliant for the most part on the assumed increased risk of suicide in this 
population, rather than the presence of active suicide risk as evidenced by a recent 
attempt. Therefore it is logical that the expected effect would be much weaker, and 
tend not to reach significance. Future studies may wish to address this by using a 
sample of psychosis patients with a 100% history of suicide attempts, preferably in 
the recent past, or by using a larger sample in which a weaker effect may be more 
easily detected. 
 
The association of increased NFT with suicidal ideation was contrary to what was 




the absence of changes in NFT. However, the odds ratio for the association was close 
to 1, indicating that if representative of a genuine association, the effect was weak. 
The finding that the association of self-reported hopelessness with suicide risk did not 
reach significance was also unexpected, since this has been a consistent finding 
demonstrated in a variety of studies over the past 40 years (Beck et al., 1985; Kovacs, 
Beck, & Weissman, 1975; McMillan et al., 2007; Salter & Platt, 1990). The most 
likely explanation for this anomaly (as well as being influential in the other non-
significant effects) is that it was necessary to reduce the measure of suicide risk to a 
binary variable (zero vs. non-zero), thereby reducing the power of the regression 
analysis to adequately model variation in suicide risk. Indeed, the model itself did not 
achieve significance, and explained only 36% of the variation in SSI despite 
containing five variables, three of which have previously been closely associated with 
suicide risk. 
 
The high number of zero scores in the patient group were likely to be a result of the 
screening questions included in the SSI. Most participants were not required to 
complete all 21 items of the measure due to endorsing statements that scored zero on 
the screening questions. It was felt that if every participant had been asked to 
complete all items participants may have been likely to endorse more statements 
carrying a non-zero score. Future studies may wish to ask all respondents to complete 
the whole questionnaire in order to introduce more variation in scores. However, this 
may have ethical implications, as completing a comprehensive suicidal ideation 





4.6 The relationship between future-directed thinking and negative 
symptoms in individuals with first episode psychosis 
This study also investigated the relationship between future-directed thinking and the 
severity of negative symptoms of psychosis. Negative symptoms are one of the most 
difficult aspects of psychosis to treat (Buchanan, 2007; Buckley & Evans, 2006) and 
have been shown to predict functional outcome up to 10 years later (Hassan & Taha, 
2011; Milev et al., 2005; Ventura et al., 2009; C. White et al., 2009) even in those at 
high risk for later psychosis (Corcoran et al., 2011), with increased symptom severity 
predicting worse outcomes. Hypothesis 4 predicted that a reduction in PFT would be 
associated with increased severity of negative symptoms, and this was supported by 
the results of the correlation analysis, which showed that severity of negative 
symptoms was negatively correlated with PFT. Severity of negative symptoms was 
also positively correlated with anxiety and self-reported hopelessness, though these 
correlations were not as strong and the association between PFT and SANS was found 
to be independent of these. It can be concluded from this that a reduction in PFT is 
independently and uniquely associated with increased severity of negative symptoms 
in psychosis.  
 
The correlation between self-reported hopelessness and negative symptoms supports 
earlier work in individuals with chronic schizophrenia (Kao et al., 2012; Lysaker et 
al., 2008; R. G. White et al., 2007) as well as those in their first episode of psychotic 
illness (Aguilar et al., 1997). It is interesting to note that the current analysis showed 
that, whilst correlated, self-reported hopelessness was not predictive of negative 




Lysaker et al. (the only one of the aforementioned studies to conduct a regression 
analysis), who reported that BHS was predictive of negative symptom severity. The 
discrepancy is likely to be due to increased power in their study due to large sample 
size (N = 143). However, a potential lack of power in the current regression analysis 
serves to highlight the implication of the result, which is that reduced PFT may be a 
stronger predictor of negative symptom severity than global self-reported 
hopelessness. 
 
It is not possible to conclude from the current results whether negative symptoms are 
a cause or an effect or reduced PFT in psychosis. However, previous work suggests 
that they may vary together. A study by Ferguson et al. (2009) employed an 
intervention to improve well-being in a group of offenders with mental illness, 
including over 90% with non-affective psychosis. The intervention focused 
specifically on improvement of goal setting and planning, which have previously been 
linked with PFT (MacLeod & Conway, 2005). The treatment had the expected result 
of increasing positive future-directed thinking and well-being, but also reduced 
negative symptoms of psychosis, suggesting that an ability to plan for and think about 
the future is connected with negative symptoms. One hypothesis emerging from this 
evidence, together with the results of the current study, is that negative symptoms 
may be closely connected with both reduced PFT and inability to plan for the future, 
which in turn may be important in predicting functional outcome. Further study into 
the relationships between PFT, negative symptoms and functional outcome could 






4.7 Strengths of the study 
4.7.1 Sample 
This study involved a novel application of the FTT to investigate future-directed 
thinking in early psychosis, its correlates, and differences from matched controls. The 
only other study to investigate FTT in psychosis to my knowledge did not compare 
future-directed thinking with that of controls (Black, 2013). In this study controls 
were well matched on age, gender, ethnicity and first language, and the sample 
included participants from a diverse mix of cultural backgrounds, increasing the 
generalizability of the study. The use of a first episode psychosis sample reduced the 
potential effects of illness chronicity in what some have argued may be a degenerative 
disorder (Rund, 2009). 
 
4.7.2 Measures and protocol 
The measures used in this study have been shown to have good reliability and are well 
validated. The data collected in the current study had a high level of internal 
consistency (Cronbach’s  alpha > .9) in most cases. The only exceptions were the 
CDSS and the SANS, which had acceptable levels of internal consistency 
(Cronbach’s  alpha  >  .7;;  Field,  2009,  Chapter  17). The protocol of this study was 
relatively short, which may have helped patients and controls alike to maintain focus 
and interest for the duration. Patient participants were seen in their usual team base, 
and whilst a few had not attended that location before, most knew the building well 
and therefore would not have been distracted from the tasks by unfamiliar 
surroundings. The protocol was administered by one researcher, and therefore inter-





4.8 Limitations of the study 
4.8.1 Design 
This study had a cross-sectional design, and thus is limited in what it can tell us about 
the causes or consequences of reduced future-directed thinking in first episode 
psychosis. It is possible to speculate from correlations about the variables that are 
associated with each other, but longitudinal research and experimental manipulations 
are needed to draw firm conclusions about causation.  
 
4.8.2 Confounding variables 
Groups were seen to differ in verbal fluency, as measured by the FAS test. This is 
problematic for interpretation of the results due to the high correlation observed 
between FAS score and FTT variables. An attempt was made to assess the impact of 
this group difference by employing ANCOVA as well as ANOVA. Whilst the group 
difference remained intact for number of events generated, it was eliminated in the 
analysis of composite score. However, the results of these analyses are challenging to 
interpret because of the intrinsic nature of cognitive deficits such as verbal fluency to 
the condition of psychosis (Heinrichs & Zakzanis, 1998). It has been argued that 
where group differences exist in a variable that is characteristic of group membership, 
covarying for this is inappropriate. This is because the effect of this is to reduce the 
amount of shared variance between the group and the dependent variable (psychosis 
and future-directed thinking) and leave a residual group variable that is difficult or 
impossible to interpret in a meaningful way (Miller & Chapman, 2001). The outcome 




effects”  (Wildt and Ahtola, 1978, cited in Miller & Chapman, 2001). It is for this 
reason that the main analyses were first undertaken without covarying for FAS, and 
the results of the ANCOVA were reported as additional analyses for completeness. 
 
Apart from a potentially intrinsic deficit related to general cognitive impairments in 
psychosis, another possible explanation for group differences in verbal fluency is the 
association between verbal fluency and education level, which has been demonstrated 
in previous work (Tombaugh et al., 1999). Patients and controls in this study were 
shown to differ significantly in education level, which may partly explain the group 
difference in verbal fluency. The group difference in education level is an important 
potential confound in the present study which should be addressed in future work. As 
with verbal fluency it was not considered appropriate for the main analyses to covary 
for education, particularly since it was measured on an ordinal, rather than continuous 
scale. A possible solution is to match controls and patients carefully on education to 
eliminate group differences in education and also potentially remove any associated 
group differences in verbal fluency. 
 
It is possible that medication affected the performance of patients on the FTT in the 
psychosis group in a positive way. It has been demonstrated that cognition in a variety 
of domains can be improved in participants on atypical medications such as clozapine, 
risperidone and olanzapine (Meltzer & McGurk, 1999). Moreover, a differential effect 
of the type of antipsychotic medication administered has been shown, with 
conventional antipsychotics resulting in little or no cognitive improvement, and 
atypical medications producing improvements in a range of cognitive domains 




directed thinking in the current study were likely to be of limited consequence, since 
large group differences were evident. Nevertheless, future studies may wish to gather 
information about the type and dosage of medication that participants are taking in 
order to study this effect more closely. Whilst research has been done on 
neurocognitive domains such as verbal and non-verbal learning and memory, 
executive function and language, the effects of antipsychotic medications on future-
directed thinking in particular are not known. 
 
An aspect of this study that may be both a strength and a limitation is the fact that the 
final diagnoses of members of the psychosis group were not known at the time of 
testing. This is due to the fact that patients recently admitted to the care of early 
intervention teams undergo a comprehensive assessment over an extended period of 
time, sometimes several months. At the time of testing final diagnosis would not have 
been available for all participants and for some psychotic disorders a diagnosis is not 
possible until symptoms have been present for a certain length of time (at least 6 
months for schizophrenia; American Psychiatric Association, 2000). Around half of 
the psychosis group in this study were tested less than 6 months after their first 
presentation to services, potentially ruling out the possibility of a final diagnosis of 
schizophrenia in these individuals at the time of testing. Membership of the patient 
group in this study was therefore not based on diagnosis, but on the clinical opinion of 
the treating team (including a psychiatrist) that clinically significant symptoms of 
psychosis had been present at the time of referral, that is, that a first episode of 





The investigation of future-directed thinking in psychosis regardless of final diagnosis 
is not necessarily a drawback, since this study aimed to discover whether the 
experience of psychotic symptoms, regardless of their origin, affects future-directed 
thinking. However, it is possible that capacity for future-directed thinking is 
dependent on diagnosis. For example, individuals with schizoaffective disorder with 
depressive symptoms may show a different pattern to those with non-affective 
psychosis. Alternatively individuals with psychosis in the context of a manic episode 
may show unusually high PFT. It is therefore possible that studying the various 
psychotic disorders together may have weakened the effects sought. Future studies 
may wish to gather information about final diagnosis after the completion of the 
study, in order to investigate any differential effects on future-directed thinking in 
different psychotic disorders. 
 
4.9 Clinical implications of the study 
The association between self-reported hopelessness and reduced PFT demonstrated in 
this study suggests that the FTT may present a quickly-administered and objective 
measure of hopelessness in individuals with first episode psychosis. It also indicates 
that interventions to improve PFT in psychosis (discussed further below) may help to 
improve hopelessness in this population. Moreover, the association of NFT with 
suicidal ideation highlights the utility of the FTT in the assessment of suicide risk. It 
is clinically significant that whilst a self-report measure (the BHS) was not a 
significant predictor of suicidal ideation, an objective measure (NFT, as measured by 
the FTT) was. Whilst the effect size was not large, this result indicates that the more 




predict suicide risk. As previously discussed, this may be connected with a reduced 
susceptibility to the effects of social desirability. 
 
This study has shown that individuals with psychosis have a significant deficit in 
future-directed thinking, both positive and negative, which is particularly pronounced 
for the medium and long term future. A reduction in PFT in particular was associated 
with increased severity of negative symptoms, and this information highlights a 
potentially fruitful avenue for future research into treatment options for negative 
symptoms and improving outcomes. PFT was shown to be most impaired for the 
period of the next year, which indicates a particular need for interventions to improve 
mid-range planning. Whilst suicidal ideation was not seen to be significantly 
associated with a reduction in PFT in this study, as discussed above it may be that the 
measure of suicide risk employed was not sensitive enough to detect the expected 
effects. It remains possible that by improving PFT suicide risk could be reduced 
through a reduction in hopelessness. 
 
The clinical implications of a reduction in NFT would seem at first to be less serious, 
indeed, given that increased NFT was associated with increased suicide ideation in 
this study it would seem wise to avoid improving capacity for NFT in individuals with 
psychosis. However, it may be that an inability to foresee difficulties or negative 
events in the future could impact on functional outcome, as it may be harder to plan 
for  future  challenges  or  foresee  the  potential  negative  consequences  of  one’s  actions 
(Eack & Keshavan, 2008). It is important to investigate the correlates and 
consequences of reduced NFT in psychosis and its relationship with suicide risk 




may also benefit from interventions to improve NFT as well as PFT, perhaps through 
efforts to improve engagement with the future as a whole. 
 
This study has also begun to uncover domains in which individuals with psychosis 
may particularly struggle to think about the future. Interventions to improve future 
thinking about relationships with others, and to improve planning for personal 
development, understanding and autonomy may prove to be effective targets for 
increasing capacity for future-directed thinking. With these implications in mind, 
Section 4.9.1 below considers some of the options for intervention. 
 
4.9.1 Interventions for future-directed thinking 
Several interventions aimed at increasing positive future thinking have been found to 
be effective. In one study (Peters, Flink, Boersma, & Linton, 2010) participants were 
asked to think about (1 minute), write about (15 minutes), and visualise (5 minutes) 
either their best possible self (positive future thinking condition) or a typical day 
(control condition). The study found that the positive future thinking task resulted in 
an increase in positive expectancies in comparison with the control task. There is 
evidence to suggest that positive self-appraisals may serve as a protective factor 
against hopelessness in psychosis (Johnson et al., 2010), therefore this intervention 
has potential for tackling reduced PFT and the risk of suicide in individuals with 
psychosis. 
 
An intervention to improve goal setting and planning has been found to improve PFT, 
hopelessness and negative symptoms, alongside its intended effects of improving 




Coates, & Hetherton, 2008) was delivered in a group setting over a period of six 
weeks to a sample of patients from a forensic rehabilitation facility and covered topics 
such as well-being, goal selection, planning, visual imaging, and problem solving 
(Ferguson et al., 2009). At the end of the programme participants reported reduced 
hopelessness and increased positive future thinking, as well as presenting with fewer 
negative symptoms of psychosis. Of the 14 individuals in the sample, 13 had a 
diagnosis of a non-affective psychotic disorder, highlighting the potential of this 
intervention to be successful in non-forensic psychosis patients. The benefit of the 
GAP programme is that it is a brief, manualised programme, and therefore with 
appropriate training could be delivered by a range of healthcare professionals without 
the need for intensive intervention. Interventions to improve employment in first 
episode psychosis are already in place in many services, and the integration of goal-
setting and planning with vocational work could result in a coherent piece of work 
centred around future planning. 
 
The concept of positive future-directed thinking is relevant to the recovery model of 
serious mental illness, in that it emphasises goal setting and planning in order to 
achieve maximum well-being for sufferers, rather than focusing on symptom 
management and aiming for complete remission from symptoms. In line with this 
model, there is potential to bring about an improvement in future-directed thinking 
through interventions to change negative beliefs about illness. Moreover, 
interventions to reduce the stigma associated with psychotic illness both in the general 
public and in individual sufferers may also have an impact on the ways in which 





It is important to note that the interventions described above are aimed only at 
improving PFT, as they are designed for use in populations where only PFT is 
impaired. However, as this study has also demonstrated deficits in NFT careful 
consideration would need to be given to the implications of improving PFT and not 
NFT. It is ethically questionable to treat only one aspect of deficit, and the 
consequences of having reduced NFT in the context of intact PFT are unknown. One 
potential consequence of having an improved ability to see positive events in the 
future in the absence of negative events or drawbacks could be the development of 
mania in those for whom psychosis occurs in the context of bipolar disorder. 
Furthermore, as mentioned previously, it is possible that a deficit in NFT is associated 
with reduced foresight, and thus leaving a deficit in this area may result in continuing 
functional disability. These matters should be considered before applying 
interventions to improve PFT. 
 
4.10 Avenues for future research 
A number of avenues for future research are suggested by this study. A study 
incorporating the improvements described in the Limitations section, such as closer 
matching of controls on education, measurement of positive symptoms and gathering 
information about medication would help to clarify the sources of deficit in future-
directed thinking in psychosis and contribute to an improved understanding of 
psychosis. Moreover, the use of a group with 100% history of suicide attempts may 





A study of future-directed thinking before and after the onset of psychosis would help 
to clarify the mechanisms behind the reduction in future-directed thinking seen in this 
population. Such a study would involve administering the FTT to individuals in an at 
risk mental state, following these people over the course of several years, and 
administering again to people who both transitioned to psychosis and also to those 
who did not. Any differences in future-directed thinking between the groups would 
provide more information about (a) whether future-directed thinking may be different 
in  people  who  transition  compared  with  those  who  don’t, and (b) whether any changes 
in future-directed thinking can be observed as a result of transition to psychosis. This 
would help to clarify whether reduced future-directed thinking is a cause or a 
consequence of psychosis. An extension of this would be to study future-directed 
thinking in psychosis over time after onset. This would help to clarify whether future-
directed thinking it stable over time, and whether any changes in future-directed 
thinking are associated with clinical symptoms, depression, anxiety or hopelessness. 
This could also allow for a prospective study of functional outcome, and its 
relationship to baseline future-directed thinking. An investigation of the effectiveness 
of interventions to improve PFT in psychosis would also be extremely useful, not only 
in investigating whether PFT can be improved in this group, but also as another way 
of finding out whether variables such as hopelessness or negative symptoms vary with 







This study set out to investigate future-directed thinking in individuals with first 
episode psychosis, including any differences from matched controls, and the 
relationships between future-directed thinking and hopelessness, suicide risk and the 
negative symptoms of psychosis. A link between reduced PFT and self-reported 
hopelessness was demonstrated, replicating previous work, confirming the validity of 
the construct of PFT as a component of hopelessness in this patient group, and 
highlighting the potential of the FTT as a tool in the measurement of hopelessness. In 
line with existing findings the results indicated that PFT was reduced in first episode 
psychosis, but in contrast with previous work NFT was also reduced, suggesting a 
general deficit in future-directed thinking overall in this population. Content analysis 
indicated that the source of this deficit may be a particularly reduced capacity for 
anticipating events involving other people, and involving personal development and 
understanding. Several potential reasons for reduced future-directed thinking in 
psychosis were hypothesised, including the direct and indirect effects of psychotic 
symptoms, brain structural or functional abnormalities, and the effects of stigma and 
discrimination on perception of the future. Interventions to help re-engage patients 
with their future may be helpful in improving functional outcomes and reducing 
suicide risk in psychosis, though careful consideration of which aspects of future-
directed thinking should be targeted is necessary. 
 
The current results were unable to replicate the result consistently found in previous 
work that reduced PFT is associated with suicide risk. It was suggested that statistical 




results reflected a true lack of association. Increased NFT was found to be associated 
with suicide risk, which was contrary to the findings of previous work. As this study 
applied the FTT in a novel population the results may reflect a genuinely different 
relationship between future-directed thinking and suicide risk in individuals with 
psychosis compared with other patient groups. Further studies will be needed to 
clarify this issue using a more sensitive measure of suicide risk. This study also 
demonstrated that, as hypothesised, reduced PFT is associated with increased severity 
of the negative symptoms of psychosis. This result is in line with previous work, and 
it was suggested that a reduced capacity  to  see  positive  events  in  one’s  future  may  
engender apathy and a lack of motivation. 
 
These results identify potentially fruitful avenues for both further research in this area 
and interventions for difficult-to-treat aspects of psychosis such as hopelessness and 
negative symptoms. Interventions for the improvement of PFT have been shown to be 
effective, and it is possible that, especially if applied in an early intervention context, 
these may prove useful, drug-free, recovery-based interventions that could 
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Dr Emmeline Goodby 
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Camden and Islington NHS Foundation Trust 
Department of Psychology 




Dear Dr Goodby 
 
Study Title: A case-control study of future-directed thinking in adults 
with first episode psychosis. 
REC reference: 13/LO/0876 
Protocol number: N/A 
IRAS project ID: 125431 
 
The Research Ethics Committee reviewed the above application at the meeting held on 21 June 
2013. Thank you for attending to discuss the application: 
 
1. The Committee wanted to clarify as to why the study was being conducted. The 
Committee queried what was hoped to be achieved from the study, including the link between 
thinking into the future and potential risk of suicide 
 
You advised with early psychosis you get a high risk of suicide. 
 
You advised the tool currently used to measure hopelessness is not specific enough. You 
advised seeing the participant’s ability and ways of thinking into the future will help with future 
possible interventions to help these participants.  
 
You advised this has not been done with this participant group before, but has been done in 
participant groups such as those with depression.  
 
2. The Committee queried if these types of participants would already know they were at risk of 
suicide.  
 
You advised not necessarily. 
 
The Committee advised these participants are just going to have a diagnosis and already feel 


quite anxious and vulnerable, and then are told they are also at risk of suicide. The Committee 
highlighted to you this would be potentially upsetting to the participant. 
 
You felt the risk of suicide may have been too strong in the PIS, and will amend the PIS to 
soften this.  
 
3. The Committee queried what you were going to do and what procedures were in place if a 
participant were to become distressed during the study. 
 
You advised the order of the questions had been considered, and there are clinical staff close 
by if a participant were to become distressed. You advised participants will be left with a contact. 
 
4. The Committee asked about the role and availability of the duty clinician.  
 
You advised no specific arrangements are in place as of yet, but will ensure this will be done 
before the study starts.  
 
5. The Committee queried as to why the GP was being informed. 
 
You felt this was out of courtesy.  
 
The Committee advised you this was not seen to be necessary. 
 
6. The Committee queried if you were excluding adults who lack capacity and how capacity will 
be assessed.  
 
You advised adults lacking capacity would be excluded from the study. You explained the 
participant will be asked about their understanding of the PIS to assess their capacity. 
 
The Committee requested you should prepare answers if the participant were to query 'why' 
they could not partake in the study. 
 
7. The Committee requested clarification as to where the interviews for the community 
volunteers were taking place. 
 
You advised this would be done in local community centres or libraries, in private rooms where 
you would not be interrupted.  
 
The Committee expressed concerns over a study using these types of participants at sites such 
as a library. The Committee queried how you were going to manage any participant distress in 
that environment appropriately. The Committee requested the library site is reconsidered.  
 
8. The Committee wanted clarification as to why the prize draw was being offered to community 
volunteers and not all participants.  
 




The Committee requested you think about including all participants in the prize draw. 
 
9. The Committee requested the PIS should state the project is an educational project. 
 
You agreed to amend. 
 
10. The Committee wanted to clarify any insurance excess would not fall on any participant. 
 
You assured the Committee this would never be the case. 
 
11. The Committee wanted to clarify why the study was not being published on a public 
database. 
 
You advised you checked this with your academic supervisor, but will be happy to look further 
into this. 
 
12. The Committee queried what would happen if the participant were to commit suicide.  
 
You advised there is no plan to then follow this up. You advised this risk is very personal and it 
is not possible to predict individuals, only the groups. 
 
13. The Committee discussed A40 of the IRAS form and felt it was unclear who would have 
access to the participant’s data, and this should be on the PIS and the consent form. 
 
You advised the Committee they are only looking at the medical records to get address and 
contact details and nothing else. You advised the Committee the participant will see the PIS 
before they access the medical records.  
 
The Committee felt if only contact details were being taken this could be done using the 
database rather than accessing personal medical records. 
 
You advised the wrong terminology may have been used, and will only need contact details and 




The documents reviewed at the meeting were: 
  
Document    Version    Date    
Advertisement  1. Community Volunteer 
Publicity Poster  
20 May 2013  
Covering Letter    20 May 2013  
Evidence of insurance or indemnity  Ltr from Zurich  01 August 2012  
GP/Consultant Information Sheets  1  20 May 2013  
Investigator CV       
Letter of invitation to participant  1  02 May 2013  


Other: Supervisor CV  A K MacLeod     
Participant Consent Form  1  20 May 2013  
Participant Information Sheet  1. Patients   20 May 2013  
Participant Information Sheet  1. Community Volunteer  20 May 2013  
Protocol  1  20 May 2013  




The Committee is unable to give an ethical opinion on the basis of the information and 
documentation received so far. Before confirming its opinion, the Committee requests that you 
provide the further information set out below. 
 
Authority to consider your response and to confirm the Committee’s final opinion has been 
delegated to the Chair and Jennifer Bostock. 
 
Further information or clarification required 
  
1. Participant Information Sheet requested changes: 
  
- The PIS titles need standardizing and the following link to be used for guidance: 
http://www.nres.nhs.uk/applications/guidance/consent-guidance-and-forms/  
The title 'What will I need to do?' needs to be softened to inform the participants they 
wouldn't specifically need to do anything to join the study. 
  
- The risk of suicide to be 'softened'.  
  
- It should state the project is an educational project. 
  
2. The validated questionnaires to be submitted for review. 
  
3. The consent form to be amended to have a section for informing the GP, and GP's contacted 
if felt appropriate.  
  
4. The researcher should prepare for answers if the participant were to query 'why' they could 
not partake in the study if they were felt not to have capacity to consent to take part.. 
  
5. The Committee expressed concern over a library as a potential site, and felt this was not 
appropriate with the nature of this study and requested they are not used for potential sites. 
  
6. The prize draw to be further considered for all participants.  
  
7. The researcher should check if the study could be published on a public database.  
  





If you would find it helpful to discuss any of the matters raised above or seek further 
clarification from a member of the Committee, you are welcome to contact Christine 
Hobson, Committee Co-ordinator. 
 
When submitting your response to the Committee, please send revised documentation where 
appropriate underlining or otherwise highlighting the changes you have made and giving revised 
version numbers and dates.   
 
If the Committee has asked for clarification or changes to any answers given in the application 
form, please do not submit a revised copy of the application form; these can be addressed in a 
covering letter to the REC. 
 
The Committee will confirm the final ethical opinion within a maximum of 60 days from the date 
of initial receipt of the application, excluding the time taken by you to respond fully to the above 
points. A response should be submitted by no later than 04 August 2013. 
 
Membership of the Committee 
 
The members of the Committee who were present at the meeting are listed on the attached 
sheet. 
 
There were no declarations of interest. 
 
Statement of compliance  
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK.  
 









Enclosures: List of names and professions of members who were present at the 
meeting and those who submitted written comments. 
 
Copy to: John Wann, Royal Holloway University of London 
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NRES Committee London - Camberwell St Giles 
Attendance at Committee meeting on 21 June 2013 
 
  
Committee Members:  
 
Name   Profession   Present    
Dr Ana Bajo  Research Psychologist   Yes  
Mrs Jennifer  Bostock  Philosopher of Psychiatry  Yes  
Prof Nelarine Cornelius  Prof. of Human Resource Management & 
Organisation Studies   
No  
Ms  Biddy Gillman  Retired Biology Teacher/ Head of year 12  Yes  
Ms  Sally  Gordon Boyd  Medical Ethicist  Yes  
Ms Alison Higgs  Lecturer - Social Work, Faculty of HSC  No  
Professor Veena Kumari  Professor of Experimental Psychology  Yes  
Dr  Alison Macrae  Solicitor  No  
Mr  John Richardson  - Chair Retired Director of COREC: Ecumenical Officer 
for Churches Together in South London   
Yes  
Mrs Hemawtee Sreeneebus  Clinical Research Nurse  Yes  
Mr  Evan  Stone QC  Retired Queen's Counsel  Yes  
Dr Mark Tanner  Consultant Psychiatrist  Yes  
Mr  James  Uwalaka  Deputy Research Study Manager  Yes  
Mr Thomas Walters  Clinical Research Nurse   No  
Mr Jonathan  Watkins  Independent Social Worker   Yes  
  
Also in attendance:  
 
Name   Position (or reason for attending)   
Miss Christine Hobson  Coordinator  
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Bristol Research Ethics Centre 






Telephone: 0117 342 1334  
 
13 August 2013 
 
Dr Emmeline Goodby 
Trainee Clinical Psychologist 
Camden and Islington NHS Foundation Trust 
Department of Psychology 





Dear Dr Goodby 
 
Study title: A case-control study of future-directed thinking in adults 
with first episode psychosis. 
REC reference: 13/LO/0876 
Protocol number: N/A 
IRAS project ID: 125431 
 
Thank you for your letter of 04 August 2013, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information was considered in correspondence by a Sub-Committee of the REC. A 
list of the sub-committee members is attached.   
 
We plan to publish your research summary wording for the above study on the NRES website, 
together with your contact details, unless you expressly withhold permission to do so.  
Publication will be no earlier than three months from the date of this favourable opinion letter.  
Should you wish to provide a substitute contact point, require further information, or wish to 
withhold permission to publish, please contact the Co-ordinator Mrs Ruth Avery, 
nrescommittee-london.camberwellstgiles@nhs.net. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 




The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
"Conditions of the favourable opinion" below). 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of the 
study. 
 
Management permission or approval must be obtained from each host organisation prior to the 
start of the study at the site concerned. 
 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System or at http://www.rdforum.nhs.uk.   
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 




The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date    
Advertisement  1. Community 
Volunteer Publicity 
Poster  
20 May 2013  
Covering Letter    20 May 2013  
Covering Letter    04 August 2013  
Evidence of insurance or indemnity  Ltr from Zurich  01 August 2012  
GP/Consultant Information Sheets  1  20 May 2013  
Investigator CV       
Letter of invitation to participant  1  02 May 2013  
Other: Supervisor CV  A K MacLeod     
Participant Consent Form  1  20 May 2013  
Participant Consent Form  2  04 August 2013  
Participant Information Sheet: Community volunteer  2  04 August 2013  
Participant Information Sheet: Patient  2  04 August 2013  
Protocol  1  20 May 2013  
Questionnaire: Calgary depression scale for schizophrenia      
Questionnaire: Generalised anxiety disorder questionnaire      
Questionnaire: Beck hopelessness scale       
Questionnaire: Beck scale for suicide ideation       
Questionnaire: Scale for the assessment of negative 
symptoms  
     
Questionnaire: Patient health questionnaire - 9       
REC application  3.5  22 May 2013  
Response to Request for Further Information    04 August 2013  
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 




The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 




You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views known 
please use the feedback form available on the website. 
 
Further information is available at National Research Ethics Service website > After Review 
 
13/LO/0876                          Please quote this number on all correspondence 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
 










Enclosures:  List of names and professions of members 
   who were present at the meeting and those who submitted written 
   comments  
 
   “After ethical review – guidance for 
   researchers” 
 
Copy to:  John Wann, Royal Holloway University of London 
   West London Mental Health NHS Trust 
    
 
 
NRES Committee London - Camberwell St Giles 
 
Attendance at Sub-Committee of the REC  
 
 
Name   Profession   Capacity    
Mrs Jennifer  Bostock  Philosopher of Psychiatry  Lay  
Mr John Richardson  Retired Director of COREC; Ecumenical Officer 
for Churches Together in South London  
Lay  
  
Also in attendance:  
 
Name   Position (or reason for attending)   





NRES Committee London - Camberwell St Giles 
 
Bristol Research Ethics Centre 
Level 3, Block B 
Whitefriars 




Tel: 0117 342 1331 
Fax: 0117 342 0445 
 
 
02 September 2013 
 
Dr Emmeline Goodby 
Trainee Clinical Psychologist 
Camden and Islington NHS Foundation Trust 
Department of Psychology 





Dear Dr Goodby 
 
Study title: A case-control study of future-directed thinking in adults 
with first episode psychosis. 
REC reference: 13/LO/0876 
Protocol number: N/A 
Amendment number: Minor Amendment 1 
Amendment date: 16 August 2013 
IRAS project ID: 125431 
 
Thank you for your letter of 16 August 2013, notifying the Committee of the above 
amendment. 
 
The Committee does not consider this to be a “substantial amendment“ as defined in the 
Standard Operating Procedures for Research Ethics Committees.  The amendment does 
not therefore require an ethical opinion from the Committee and may be implemented 
immediately, provided that it does not affect the approval for the research given by the R&D 




The documents received were as follows: 
 
 Document  Version  Date  
Letter of invitation to participant  2  04 August 2013  
GP/Consultant Information Sheets  2  04 August 2013  
Notification of a Minor Amendment    16 August 2013  
  
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
 











Copy to: West London Mental Health NHS Trust 






NRES Committee London - Camberwell St Giles 
Bristol Research Ethics Centre 





Tel: 0117 3421391 
 
 
03 February 2014 
 
Dr Emmeline Goodby 
Trainee Clinical Psychologist 
Camden and Islington NHS Foundation Trust 
Department of Psychology 





Dear Dr Goodby 
 
Study title: A case-control study of future-directed thinking in adults 
with first episode psychosis. 
REC reference: 13/LO/0876 
Protocol number: N/A 
Amendment number: 1 
Amendment date: 27 January 2014 
IRAS project ID: 125431 
 




There were no outstanding ethical issues.  
 
The members of the Committee taking part in the review gave a favourable ethical opinion of 





The documents reviewed and approved at the meeting were: 
 
 Document  Version  Date  
Notice of Substantial Amendment (non-CTIMPs)    27 January 2014  
Community Volunteer Print Media Advertisement  1  23 January 2014  


Community Volunteer Publicity Leaflet  1  23 January 2014  
Community Volunteer Publicity Poster  2  23 January 2014  
  
Membership of the Committee 
 




All investigators and research collaborators in the NHS should notify the R&D office for the 
relevant NHS care organisation of this amendment and check whether it affects R&D approval 
of the research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
 












Enclosures: List of names and professions of members who took part in the review 
 
Copy to:  West London Mental Health NHS Trust 




NRES Committee London - Camberwell St Giles 
 
Attendance at Sub-Committee of the REC meeting on 07 February 2014 
 
Name   Profession   Capacity    
Mrs Jennifer Bostock  Philosopher of Psychiatry  Lay  
Ms Sally Gordon Boyd  Medical Ethicist  Lay  
Mr John Richardson (chair) Retired Director of COREC; Ecumenical 




Also in attendance:  
 
Name   Position (or reason for attending)   







Ref: 2013/078R1 Ethics Form Approved




Applicant Name: Emmeline Goodby
 
Application title: Future-Directed Thinking in First Episode Psychosis
 
Gmail - Ref: 2013/078R1 Ethics Form Approved https://mail.google.com/mail/u/0/?ui=2&ik=26aff8d4d8&vi...







Letters of Research and Development approval 















Information sheet for patient participants 
Patient Volunteer Information Sheet, Version , 2, 4
th
 August 2013 






Participant Information Sheet – Patient Volunteer 
 
Future-Directed Thinking in First Episode Psychosis 
 
You are being invited to take part in a research study.  Before you decide whether or not to 
take part it is important for you to understand why the research is being done and what it will 
involve.  Please read the following information and discuss it with other people if you wish.  
We encourage you to ask questions if anything is not clear or if you would like more 
information.  Contact details are at the end of this information sheet. 
 
What is the purpose of the study? 
This in an educational study that is being done to try and find out more about early psychosis, 
in particular the links between views about the future, hopelessness, and suicide.  We also aim 
to try to find out whether there is a link between views of the future and the ‘negative’ 
symptoms of psychosis such as lack of energy, feeling less emotional and lack of motivation. 
 
Why have I been invited? 
You have been chosen because you have had a first episode of psychosis within the last 12 
months. 
 
Do I have to take part? 
It is up to you to decide to join the study.  We will describe the study and go through this 
information sheet with you.  If you agree to participate you will be asked to sign a consent 
form.  This does not place you under any obligation, and if at a later point you want to stop 
participating you will be able to do so without having to explain why.  Your decision will not 
affect any future treatment by the NHS. 
 
What will happen to me if I take part? 
If you decide to take part you will need to meet with a researcher at your care team’s base to 
complete some psychological tests and some questionnaires about your illness and symptoms.  
You do not need to have any knowledge of the tests or questionnaires beforehand.  The 
session should take between 45-60 minutes, and you can take breaks. 
 
Expenses and payment 





Doctoral Course in Clinical Psychology 
Department of Psychology 
Patient Volunteer Information Sheet, Version , 2, 4th August 2013 
Page 2 of 3 
Involvement of the General Practitioner/Family Doctor (GP) 
If we feel it is appropriate we will write to your GP telling him/her of your decision to 
participate, unless you ask us not to.  We will ask you before we do this, and you are free to 
say no. 
 
Will my taking part in the study be kept confidential? 
Paper documents relating to the study will not have your name on them and nobody except 
the researcher will know they relate to you.  Electronic documents relating to the study will be 
kept on a securely encrypted memory stick, and only the chief investigator will have access to 
this. 
 
Everything you tell the researcher will be kept confidential within the research study.  As is 
normal in research studies, the only exception to this is if the researcher becomes concerned 
that there is a significant risk of harm either to you or to someone else.  In this case, the 
researcher will be obliged to inform your care coordinator or another appropriate professional 
so that they can help to keep anyone at risk safe.  The researcher will make every effort to tell 
you before they do this. 
 
What will happen to any information I give? 
Anonymised information from the study may be used: 
x By storing and analysing it electronically to find out what this study is telling us. 
x By sharing it with groups that check that research is done properly. 
x By publishing the results of the study (this will not include any information that 
identifies you to people outside the study). 
All personal information will be destroyed after the end of the study. 
 
Who has reviewed this study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests.  This research study has been reviewed and given 
a favourable opinion by the Camberwell St Giles Research Ethics Committee. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, in the first instance you should speak to 
the researcher who will do their best to answer your questions (contact details below).  If you 
remain unhappy and wish to complain formally the researcher will be able to provide details 
of how to do this.  In the unlikely event of anything untoward happening insurance has been 
taken out with Zurich Municipal to cover this study. 
 
Further information and contact details 
We would be very happy to answer any questions you have.  Please don’t hesitate to contact 




Patient Volunteer Information Sheet, Version , 2, 4th August 2013 
Page 3 of 3 
Dr Emmeline Goodby 
Doctorate Course in Clinical Psychology 
Department of Psychology 
Royal Holloway, University of London 











Poster and leaflet advertisements for control participants 






What is the purpose of the study? 
This study is being done to try and find out more about early psychosis.  Psychosis is an 
illness that commonly involves the experience of hallucinations, delusions and/or paranoia, 
and is associated with an increased risk of suicide in the first years of the illness.  The study 
will focus on the links between views about the future, hopelessness, and risk of suicide in 
early psychosis.  We also aim to try to find out whether there is a link between views of the 
future and a particular type of symptoms of psychosis. 
 
What will happen if I take part? 
Participants will be required to complete straightforward psychological tests and 
questionnaires at a convenient location, taking between 45-60 minutes. 
 
Who can take part? 
Men and women without psychosis between the ages of 18 and 35 are potentially eligible to 
take part.  People who are currently suffering from clinical anxiety or depression are not 
eligible to take part. 
 
Compensation 
Community volunteers will be entered into a prize draw to win one of three cash prizes.   
1st prize: £100, 2nd prize: £50, 3rd prize: £25 
You will have a better than one-in-ten chance of winning a prize! 
 
Interested? 
If you are interested in participating or would like more information please contact: 
Dr Emmeline Goodby 
07936 888454 
emmeline.goodby@nhs.net 
Doctoral Course in Clinical Psychology 
Department of Psychology 
Win a cash prize! 
 
Volunteers Wanted for a Research Study: 
Future Thinking in First Episode Psychosis 
 
We are looking for volunteers between the ages of 18 and 35 to 


















Full details are overleaf. 
If you are interested, contact: 
Dr Emmeline Goodby 
07936 888454 
emmeline.goodby@nhs.net 
Win a cash prize! 
 
Volunteers Wanted for a Research Study: 
Future Thinking in First Episode Psychosis 
 
We are looking for volunteers between the 
ages of 18 and 35 to take part in a short 
research study.  You could win up to £100! 
Doctoral Course in Clinical Psychology 
Department of Psychology 
	

What is the purpose of the study? 
This study is being done to try and find out more about early 
psychosis.  Psychosis is an illness that commonly involves the 
experience of hallucinations, delusions and/or paranoia, and is 
associated with an increased risk of suicide in the first years of the 
illness.  The study will focus on the links between views about the 
future, hopelessness, and risk of suicide in early psychosis.  We 
also aim to try to find out whether there is a link between views of 
the future and a particular type of symptoms of psychosis. 
 
What will happen if I take part? 
Participants will be required to complete straightforward 
psychological tests and questionnaires at a convenient location, 
taking between 45-60 minutes. 
 
Who can take part? 
Men and women without psychosis between the ages of 18 and 35 
are potentially eligible to take part.  People who are currently 




Community volunteers will be entered into a prize draw to win 
one of three cash prizes. 
 
1st prize: £100, 2nd prize: £50, 3rd prize: £25 
 







Information sheet for control participants 
  
Community Volunteer Information Sheet, Version 2, 4th August 2013 






Participant Information Sheet – Community Volunteer 
 
Future-Directed Thinking in First Episode Psychosis 
 
You are being invited to take part in a research study.  Before you decide whether or not to 
take part it is important for you to understand why the research is being done and what it will 
involve.  Please read the following information and discuss it with other people if you wish.  
We encourage you to ask questions if anything is not clear or if you would like more 
information.  Contact details are at the end of this information sheet. 
 
 What is the purpose of the study? 
This is an educational study that is being done to try and find out more about early psychosis.  
Psychosis is an illness that commonly involves the experience of hallucinations, delusions 
and/or paranoia, and in previous research the rate of suicide in this group has been shown to 
be higher than in people without psychosis.  The study will focus on the links between views 
about the future, hopelessness, and risk of suicide in early psychosis.  We also aim to try to 
find out whether there is a link between views of the future and particular symptoms of 
psychosis. 
 
Who can take part? 
Men and women without psychosis between the ages of 18 and 35 are potentially eligible to 
take part.  People who are currently suffering from clinical anxiety or depression are not 
eligible to take part. 
 
Do I have to take part? 
It is up to you to decide to join the study.  We will describe the study and go through this 
information sheet with you.  If you agree to participate you will be asked to sign a consent 
form.  This does not place you under any obligation, and if at a later point you want to stop 
participating you will be able to do so without having to explain why.  Your decision will not 
affect any future treatment by the NHS. 
 
What will happen to me if I take part? 
If you decide to take part you will need to complete a brief telephone questionnaire to find out 
whether you are eligible to take part in the study.  You will then meet with a researcher to 
complete some psychological tests and questionnaires.  You do not need to have any 
knowledge of the tests or questionnaires beforehand.  The session should take between 45-60 
minutes, and you can take breaks. 
 
 
Doctoral Course in Clinical Psychology 
Department of Psychology 
Community Volunteer Information Sheet, Version 2, 4th August 2013 
Page 2 of 3 
Expenses and payment 
Not every participant will be paid.  Instead, all 26 community volunteers will be entered into a 
prize draw to win one of three cash prizes.  1st prize: £100, 2nd prize: £50, 3rd prize: £25.  You 
will have a better than one-in-ten chance of winning a prize. 
  
Involvement of the General Practitioner/Family Doctor (GP) 
If we feel it is appropriate we will write to your GP telling him/her of your decision to 
participate, unless you ask us not to.  We will ask you before we do this, and you are free to 
say no. 
 
Will my taking part in the study be kept confidential? 
Paper documents relating to the study will not have your name on them and nobody except 
the researcher will know they relate to you.  Electronic documents relating to the study will be 
kept on a securely encrypted memory stick, and only the chief investigator will have access to 
this. 
 
Everything you tell the researcher will be kept confidential within the research study.  As is 
normal in research studies, the only exception to this is if the researcher becomes concerned 
that there is a significant risk of harm either to you or to someone else.  In this case, the 
researcher will be obliged to inform your GP or another appropriate professional so that they 
can help to keep anyone at risk safe.  The researcher will make every effort to tell you before 
they do this. 
 
What will happen to any information I give? 
Anonymised information from the study may be used: 
x By storing and analysing it electronically to find out what this study is telling us. 
x By sharing it with groups that check that research is done properly. 
x By publishing the results of the study (this will not include any information that 
identifies you to people outside the study). 
All personal information will be destroyed after the end of the study. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests.  This study has been reviewed and given a 
favourable opinion by Camberwell St Giles Research Ethics Committee. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, in the first instance you should speak to 
the researcher who will do their best to answer your questions (contact details below).  If you 
remain unhappy and wish to complain formally the researcher will be able to provide details 
of how to do this.  In the unlikely event of anything untoward happening insurance has been 
taken out with Zurich Municipal to cover this study. 
 
Community Volunteer Information Sheet, Version 2, 4th August 2013 
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Further information and contact details 
We would be very happy to answer any questions you have.  Please don’t hesitate to contact 
us using the details given below. 
 
Dr Emmeline Goodby 
Doctoral Course in Clinical Psychology 
Department of Psychology 
Royal Holloway, University of London 









Ofqual educational equivalence levels 
Level NQF Qualifications examples QCF Qualifications examples Framework for Higher Education 
examples 
Entry 
 Entry level certificates 
 Skills for Life at Entry level 
Entry level VQs: 
 Entry level awards, certificates and 
diplomas 
 Foundation Learning Tier pathways 
 Functional Skills at Entry level 
- 
1 
 GCSEs graded D-G 
 NVQs at level 1 
 Key Skills level 1 
 Skills for Life 
 Foundation Diploma 
Level 1 VQs: 
 BTEC awards, certificates and diplomas at 
level 1 
 Functional Skills level 1 
 OCR Nationals 
 Foundation Learning Tier pathways  
- 
2 
 GCSEs graded A*-C 
 NVQs at level 2 
 Level 2 VQs 
 Key Skills level 2 
 Skills for Life 
 Higher Diploma 
Level 2 VQs: 
 
 BTEC awards, certificates and diplomas at 
level 2 
 Functional Skills level 2  
- 
3 
 AS/A levels 
 Advanced Extension Awards 
 International Baccalaureate 
 Key Skills level 3 
 NVQs at level 3 
 Cambridge International Awards 
 Advanced and Progression Diploma 
Level 3 VQs: 
 
 BTEC awards, certificates and diplomas at 
level 3 
 BTEC Nationals 





Level NQF Qualifications examples QCF Qualifications examples Framework for Higher Education 
examples 
4 
 NVQs at level 4 
 Key Skills level 4 




Level 4 VQs: 
 BTEC Professional Diplomas, 
Certificates and Awards 
Certificates of higher education 
5 
 Higher national diplomas 
 Other higher diplomas 
 NVQs at level 4* 
Level 5 VQs: 
 HNCs and HNDs 
 BTEC Professional Diplomas, 
Certificates and Awards  
Diplomas of higher education and 
further education, foundation degrees 
and higher national diplomas 
6 
 National Diploma in Professional 
Production Skills 
 NVQs at level 4* 
Level 6 VQs: 
 BTEC Advanced Professional 
Diplomas, Certificates and 
Awards  
Bachelor degrees, graduate 
certificates and diplomas 
7 
 Postgraduate certificates and diplomas 
 BTEC advanced professional awards, 
certificates and diplomas 
 Fellowships and fellowship diplomas 
 Diploma in Translation 




Level 7 VQs: 
 Advanced professional awards, 
certificates and diplomas  
Masters degrees, postgraduate 
certificates and diplomas 
8 
 NVQs at level 5* Level 8 VQs: 
 Award, certificate and diploma 
in strategic direction  
Doctorates 




Beck Hopelessness Scale 








Beck Scale for Suicide Ideation 





























Nancy C. Andreasen, M.D., Ph.D. 
 
Department of Psychiatry 
College of Medicine 
The University of Iowa 





Copyright by Nancy C. Andreasen, 1984 
(SAS Variable Name edition: 2000) 
 
  __ __2 
AFFECTIVE FLATTENING OR BLUNTING 
 
Affective flattening or blunting manifests itself as a characteristic impoverishment of emotional expression, reactivity, 
and feeling.  Affective flattening can be evaluated by observation of the subject's behavior and responsiveness 
during a routine interview.  The rating of some items may be affected by drugs, since the Parkinsonian side-effect of 
phenothiazines may lead to mask-like facies and diminished associated movements.  Other aspects of affect, such 
as responsivity or appropriateness, will not be affected, however. 
 
Unchanging Facial Expression 
The subject's face appears wooden, mechanical, 
frozen.  It does not change expression, or 
changes less than normally expected, as the 
emotional content of discourse changes.  Since 
phenothiazines may partially mimic this effect, 
the interviewer should be careful to note whether 
or not the subject is on medication, but should 
not try to "correct" the rating accordingly. 
 
Not at all:  Subject is normal or labile 0 SS11 
 
Questionable decrease 1 
 
Mild:  Occasionally the subject's 
expression is not as full as expected 2 
 
Moderate:  Subject's expressions are 
dulled overall, but not absent 3 
 
Marked:  Subject's face has a flat "set" 
look, but flickers of affect arise 
occasionally 4 
 
Severe:  Subject's face looks "wooden" 
and changes little, if at all throughout 
the interview 5 
 
 
Decreased Spontaneous Movements 
The subject sits quietly throughout the interview 
and shows few or no spontaneous movements.  
He does not shift position, move his legs, move 
his hands, etc., or does so less than normally 
expected. 
Not at all:  Subject moves normally or is 
overactive 0  SS12 
 
Questionable decrease 1 
 
Mild:  Some decrease in spontaneous 
movements 2 
 
Moderate:  Subject moves three or four 
times during the interview 3 
 
Marked:  Subject moves once or twice 
during the interview 4 
 
Severe:  Subject sits immobile 
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  __ __3 
Paucity of Expressive Gestures 
The subject does not use his body as an aid in 
expressing his ideas, through such means as 
hand gestures, sitting forward in his chair when 
intent on a subject, leaning back when relaxed, 
etc.  This may occur in addition to decreased 
spontaneous movements. 
Not at all:  Subject uses expressive 
gestures normally or excessively 0  SS13 
 
Questionable decrease 1 
 
Mild:  Some decrease in expressive 
gestures 2 
 
Moderate:  Subject uses body as an aid 
in expression at least three or four times 3 
 
Marked:  Subject uses body as an aid in 
expression only once or twice 4 
 
Severe:  Subject never uses body as an 
aid in expression 5 
 
 
Poor Eye Contact 
The subject avoids looking at others or using his 
eyes as an aid in expression.  He appears to be 
staring into space even when he is talking. 
Not at all:  Good eye contact and 
expression 0  SS14 
 
Questionable decrease 1 
 
Mild:  Some decrease in eye contact and 
eye expression 2 
 
Moderate:  Subject's eye contact is 
decreased by at least half of normal 3 
 
Marked:  Subject's eye contact is very 
infrequent 4 
 





Failure to smile or laugh when prompted may be 
tested by smiling or joking in a way which would 
usually elicit a smile from a normal individual.  
The examiner may also ask, "Have you forgotten 
how to smile?" while smiling himself. 
Not at all 0  SS15 
 
Questionable decrease 1 
 
Mild:  Slight but definite lack in 
responsivity 2 
 
Moderate:  Subject occasionally seems 
to miss the cues to respond  3 
 
Marked:  Subject seems to miss the 
cues to respond most of the time 4 
 
Severe:  Subject is essentially 




  __ __4 
Lack of Vocal Inflections 
While speaking the subject fails to show normal 
vocal emphasis patterns.  Speech has a 
monotonic quality, and important words are not 
emphasized through changes in pitch or volume.  
Subject also may fail to change volume with 
changes of subject so that he does not drop his 
voice when discussing private topics nor raise it 
as he discusses things which are exciting or for 






Global Rating of Affective Flattening 
The global rating should focus on overall severity 
of affective flattening or blunting.  Special 
emphasis should be given to such core features 
as unresponsiveness, inappropriateness, and an 
overall decrease in emotional intensity. 
Not all all:  Normal vocal inflections 0 SS16 
 
Questionable decrease 1 
 
Mild:  Slight decrease in vocal inflections 2 
 
Moderate:  Interviewer notices several 
instances of flattened vocal inflections 3 
 
Marked:  Obvious decrease in vocal 
inflections 4 
 
Severe:  Subject's speech is a 




No flattening:  Normal affect 0 SS17 
 
Questionable affective flattening 1 
 
Mild affective flattening 2 
 
Moderate affective flattening 3 
 
Marked affective flattening 4 
 




Affect expressed is inappropriate or 
incongruous, not simply flat or blunted.  Most 
typically, this manifestation of affective 
disturbance takes the form of smiling or 
assuming a silly facial expression while talking 
about a serious or sad subject.  (Occasionally 
subjects may smile or laugh when talking about 
a serious subject which they find uncomfortable 
or embarrassing.  Although their smiling may 
seem inappropriate, it is due to anxiety and 
therefore should not be rated as inappropriate 
affect.)  Do not rate affective flattening or 









Mild:  At least one instance of 
inappropriate smiling or other 
inappropriate affect 2 
 
Moderate:  Subject exhibits two to four 
instances of inappropriate affect 3 
 
Marked:  Subject exhibits five to ten 
instances of inappropriate affect 4 
 
Severe:  Subject's affect is inappropriate 








Alogia is a general term coined to refer to the impoverished thinking and cognition that often occur in subjects with 
schizophrenia (Greek a = no, none; logos = mind, thought).  Subjects with alogia have thinking processes that seem 
empty, turgid, or slow.  Since thinking cannot be observed directly, it is inferred from the subject's speech.  The two 
major manifestations of alogia are nonfluent empty speech (poverty of speech) and fluent empty speech (poverty of 
content of speech).  Blocking and increased latency or response may also reflect alogia. 
 
Poverty of Speech 
Restriction in the amount of spontaneous 
speech, so that replies to questions tend to be 
brief, concrete, and unelaborated.  
Unprompted additional information is rarely 
provided.  Replies may be monosyllabic, and 
some questions may be left unanswered 
altogether.  When confronted with this speech 
pattern, the interviewer may find himself 
frequently prompting the subject in order to 
encourage elaboration of replies.  To elicit this 
finding, the examiner must allow the subject 
adequate time to answer and to elaborate his 
answer. 
No poverty of speech:  A substantial and 
appropriate number of replies to questions include 
additional information 0 SS19 
 
Questionable poverty of speech 1 
 
Mild:  Occasional replies do not include elaborated 
information even though this is appropriate 2 
 
Moderate:  Some replies do not include 
appropriately elaborated information, and some 
replies are monosyllabic or very brief--("Yes."  
"No."  "Maybe."  "I don't know."  "Last week.") 3 
 
Marked:  Answers are rarely more than a sentence 
or a few words in length 4 
 
Severe:  Subject says almost nothing and 
occasionally fails to answer questions 5 
 
 
  __ __6 
 
Poverty of Content of Speech 
Although replies are long enough so that speech 
is adequate in amount, it conveys little 
information.  Language tends to be vague, often 
over-abstract or over-concrete, repetitive, and 
stereotyped.  The interviewer may recognize this 
finding by observing that the subject has spoken 
at some length but has not given adequate 
information to answer the question.  
Alternatively, the subject may provide enough 
information, but require many words to do so, so 
that a lengthy reply can be summarized in a 
sentence or two.  Sometimes the interviewer 
may characterize the speech as "empty 
philosophizing." 
 
Exclusions:  This finding differs from 
circumstantiality in that the circumstantial subject 
tends to provide a wealth of detail. 
 
Example:  Interviewer:  "Why is it, do you think, 
that people believe in God?"  Subject:  "Well, 
first of all because he uh, he are the person that 
is their personal savior.  He walks with me and 
talks with me.  And uh, the understanding that I 
have, um, a lot of peoples, they don't really, uh, 
know they own personal self.  Because, uh, they 
ain't, they all, just don't know they personal self.  
They don't, know that he uh, seemed like to me, 
a lot of 'em don't understand that he walks and 
talks with them." 




Mild:  Occasional replies are too vague 
to be comprehensible or can be 
markedly condensed 2 
 
Moderate:  Frequent replies which are 
vague or can be markedly condensed 
to make up at least a quarter of the 
interview 3 
 
Marked:  At least half of the subject's 
speech is composed of vague or 
incomprehensible replies 4 
 
Severe:  Nearly all the speech is vague, 





Interruption of a train of speech before a thought 
or idea has been completed.  After a period of 
silence which may last from a few seconds to 
minutes, the person indicates that she/he cannot 
recall what he had been saying or meant to say.  
Blocking should only be judged to be present if a 
person voluntarily describes losing his thought or 
if, upon questioning by the interviewer, the 
person indicates that that was the reason for 
pausing. 




Mild:  A single instance noted during a 
forty-five minute period 2 
 
Moderate:  Occurs twice during forty-five 
minutes 3 
 
Marked:  Occurs three or four times 
during forty-five minutes 4 
 
Severe:  Occurs more than four times in 
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Increased Latency of Response 
The subject takes a longer time to reply to questions 
than is usually considered normal.  He may seem 
"distant" and sometimes the examiner may wonder if 
he has even heard the question.  Prompting usually 
indicates that the subject is aware of the question, 
but has been having difficulty in formulating his 
thoughts in order to make an appropriate reply. 
Not at all 0 SS22
Questionable 1 
Mild:  Occasional brief pauses before 
replying 2 
Moderate:  Often pauses several seconds 
before replying 3 
Marked:  Usually pauses at least ten to 
fifteen seconds before replying 4 
Severe:  Long pauses prior to nearly all 
replies. 5 
 
Global Rating of Alogia 
Since the core features of alogia are poverty of 
speech and poverty of content of speech, the global 
rating should place particular emphasis on them. 
No alogia 0 SS23
Questionable 1 
Mild:  Mild but definite impoverishment in 
thinking 2 
Moderate:  Significant evidence for 
impoverished thinking 3 
Marked:  Subject's thinking seems 
impoverished much of the time 4 
Severe:  Subject's thinking seems 




Avolition manifests itself as a characteristic lack of energy, drive, and interest.  Subjects are unable to mobilize 
themselves to initiate or persist in completing many different kinds of tasks.  Unlike the diminished energy or interest 
of depression, the avolitional symptom complex in schizophrenia is usually not accompanied by saddened or 
depressed affect.  The avolitional symptom complex often leads to severe social and economic impairment. 
 
Grooming and Hygiene 
The subject displays less attention to grooming 
and hygiene than normal.  Clothing may appear 
sloppy, outdated, or soiled.  The subject may bathe 
infrequently and not care for hair, nails, or teeth--
leading to such manifestations as greasy or 
uncombed hair, dirty hands, body odor, or unclean 
teeth and bad breath.  Overall, the appearance is 
dilapidated and disheveled.  In extreme cases, the 
subject may even have poor toilet habits. 
 
How often do you bathe or shower? 
 
Do you change your clothes every day? 
 
How often do you do laundry? 





Mild:  Some slight but definite indication of 
inattention to appearance, i.e., messy hair 
or disheveled clothes 2 
 
Moderate:  Appearance is somewhat 
disheveled, i.e., greasy hair, dirty clothes 3 
 
Marked:  Subject's attempts to keep up 
grooming or hygiene are minimal 4 
 
Severe:  Subject's clothes, body and 
environment are dirty and smelly 5 
 
 
Impersistence at Work or School 
The subject has had difficulty in seeking or maintaining No evidence of impersistence at work 
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employment (or schoolwork) as appropriate for his or 
her age and sex.  If a student, he/she does not do 
homework and may even fail to attend class.  Grades 
will tend to reflect this.  If a college student, there may 
be a pattern of registering for courses, but having to 
drop several or all of them before the semester is 
completed.  If of working age, the subject may have 
found it difficult to work at a job because of inability to 
persist in completing tasks and apparent 
irresponsibility.  He may go to work irregularly, wander 
away early, complete them in a disorganized manner.  
He may simply sit around the house and not seek any 
employment or seek it only in an infrequent and 
desultory manner.  If a housewife or retired person, the 
subject may fail to complete chores, such as shopping 
or cleaning, or complete them in an apparently 
careless and half-hearted way. 
 
Have you been having any problems at (work, school)? 
 
Do you ever start some project and just never get 
around to finishing it? 




Mild:  Slight indications of 
impersistence, i.e., missing a couple 
days of school or work 2 
 
Moderate:  Subject often has poor 
performance at work or school 3 
 
Marked:  Subject has much difficulty 
maintaining even a below normal level 
of work or school 4 
 
Severe:  Subject consistently fails to 
maintain a record at work or school 5 
 
Physical Anergia 
The subject tends to be physically inert.  He may sit in a 
chair for hours at a time and not initiate any 
spontaneous activity.  If encouraged to become involved 
in an activity, he may participate only briefly and then 
wander away or disengage himself and return to sitting 
alone.  He may spend large amounts of time in some 
relatively mindless and physically inactive task such as 
watching TV or playing solitaire.  His family may report 
that he spends most of his time at home "doing nothing 
except sitting around".  Either at home or in an inpatient 
setting he may spend much of his time sitting in his 
room. 
 
Are there times when you lie or sit around most of the 
day? 
 
(Does this ever last longer than one day?) 




Mild Anergia 2 
 
Moderate:  Subject lies in bed or sits 
immobile at least a quarter of normal 
waking hours 3 
 
Marked:  Subject lies in bed or sits 
immobile at least half of normal 
waking hours 4 
 
Severe:  Subject lies in bed or sits 
immobile for most of the day 5 
 
Global Rating of Avolition - Apathy 
The global rating should reflect the overall severity of 
the avolition symptoms, given expectational norms for 
the subject's age and social status or origin.  In making 
the global rating, strong weight may be given to only 
one or two prominent symptoms if they are particularly 
striking. 




Mild, But Definitely Present 2 
 
Moderate Avolition 3 
 
Marked Avolition 4 
 
Severe Avolition 5 
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ANHEDONIA-ASOCIALITY 
 
This symptom complex encompasses the schizophrenic subject's difficulties in experiencing interest or pleasure.  It 
may express itself as a loss of interest in pleasurable activities, an inability to experience pleasure when participating 
in activities normally considered pleasurable, or a lack of involvement in social relationships of various kinds. 
 
Recreational Interests and Activities 
The subject may have few or no interests, 
activities, or hobbies.  Although this symptom 
may begin insidiously or slowly, there will usually 
be some obvious decline from an earlier level of 
interest and activity.  Subjects with relatively 
milder loss of interest will engage in some 
activities which are passive or non-demanding, 
such as watching TV, or will show only 
occasional or sporadic interest.  Subjects with 
the most extreme loss will appear to have a 
complete and intractible inability to become 
involved in or enjoy activities.  The rating in this 
area should take both the quality and quantity of 
recreational interests into account. 
 
Have you felt interested in the things you usually 
enjoy? 
 
(Have they been as fun as usual?) 
 
Have you been watching TV or listening to the 
radio? 
No Inability to Enjoy Recreational 




Mild Inability to Enjoy Recreational 
Activities 2 
 
Moderate:  Subject often is not "up" for 
recreational activities 3 
 
Marked:  Subject has little interest in and 
derives only mild pleasure from 
recreational activities 4 
 
Severe:  Subject has no interest in and 
derives no pleasure from recreational 
activities 5 
 
Sexual Interest and Activity 
The subject may show a decrement in sexual 
interest and activity, as judged by what would be 
normal for the subject's age and marital status.  
Individuals who are married may manifest 
disinterest in sex or may engage in intercourse 
only at the partner's request.  In extreme cases, 
the subject may not engage in any sex at all.  
Single subjects may go for long periods of time 
without sexual involvement and make no effort to 
satisfy this drive.  Whether married or single, 
they may report that they subjectively feel only 
minimal sex drive or that they take little 
enjoyment in sexual intercourse or in 
masturbatory activity even when they engage in 
it. 
 
Have you noticed any changes in your sex 
drive? 
No Inability to Enjoy Sexual Activities 0 SS29
 
Questionable Decrement in Sexual 
Interest and Activity 1 
 
Mild Decrement in Sexual Interest and 
Activity 2 
 
Moderate:  Subject occasionally has 
noticed decreased interests in and/or 
enjoyment from sexual activities 3 
 
Marked:  Subject has little interest in 
and/or derives little pleasure from sexual 
activities 4 
 
Severe:  Subject has no interest in 
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Ability to Feel Intimacy and Closeness 
The subject may display an inability to form close 
and intimate relationships of a type appropriate for 
his age, sex, and family status.  In the case of a 
younger person, this area should be rated in terms 
of relationships with the opposite sex and with 
parents and siblings.  In the case of an older person 
who is married, the relationship with spouse and 
with children should be evaluated, while older 
unmarried individuals should be judged in terms of 
relationships with the opposite sex and any family 
members who live nearby.  Subjects may display 
few or no feelings of affection to available family 
members.  Or they may have arranged their lives so 
that they are completely isolated from any intimate 
relationships, living alone and making no effort to 
initiate contacts with family or members of the 
opposite sex. 
 
Have you been having any problems with your 
(family, spouse)? 
 
How would you feel about visiting with your (family, 
parents, spouse, etc.)? 
No Inability to Feel Intimacy and 
Closeness 0 SS30
Questionable Inability 1 
Mild, But Definite Inability to Feel Intimacy 
and Closeness 2 
Moderate:  Subject appears to enjoy family 
or significant others but does not appear to 
"look forward" to visits 3 
Marked:  Subject appears neutral toward 
visits from family or significant others.  
Brightens only mildly 4 
Severe:  Subject prefers no contact with or 
is hostile toward family or significant others 5 
 
Relationships with Friends and Peers 
Subjects may also be relatively restricted in their 
relationships with friends and peers of either sex.  
They may have few or no friends, make little or no 
effort to develop such relationships, and choose to 
spend all or most of their time alone. 
 
Have you been spending much time with friends? 
 
Do you enjoy spending time alone, or would you 
rather have more friends? 
No Inability to Form Close Friendships 0 SS31
Questionable Inability to Form Friendships 1 
Mild, But Definite Inability to Form 
Friendships 2 
Moderate:  Subject able to interact, but 
sees friends/acquaintances only two to 
three times per month 3 
Marked:  Subject has difficulty forming 
and/or keeping friendships.  Sees 
friends/acquaintances only one to two 
times per month 4 
Severe:  Subject has no friends and no 
interest in developing any social ties 5 
 
Global Rating of Anhedonia-Asociality 
The global rating should reflect the overall severity 
of the anhedonia-asociality complex, taking into 
account the norms appropriate for the subject's 
age, sex, and family status. 
No Evidence of Anhedonia-Asociality 0 SS32
Questionable Evidence of Anhedonia-
Asociality 1 
Mild, But Definite Evidence of Anhedonia-
Asociality 2 
Moderate Evidence of Anhedonia-Asociality 3 
Marked Evidence of Anhedonia-Asociality 4 
Severe Evidence of Anhedonia-Asociality 5 
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ATTENTION 
 
Attention is often poor in schizophrenics.  The subject may have trouble focusing his attention, or he may only be 
able to focus sporadically and erratically.  He may ignore attempts to converse with him, wander away while in the 
middle of an activity or task, or appear to be inattentive when engaged in formal testing or interviewing.  He may or 
may not be aware of his difficulty in focusing his attention. 
 
Social Inattentiveness 
While involved in social situations or activities, 
the subject appears inattentive.  He looks away 
during conversations, does not pick up the topic 
during a discussion, or appears uninvolved or 
unengaged.  He may abruptly terminate a 
discussion or a task without any apparent 
reason.  He may seem "spacy" or "out of it".  He 
may seem to have poor concentration when 
playing games, reading, or watching TV. 
No Indication of Inattentiveness 0 SS33
 
Questionable Signs 1 
 
Mild, But Definite Signs of 
Inattentiveness 2 
 
Moderate:  Subject occasionally misses 
what is happening in the environment 3 
 
Marked:  Subject often misses what is 
happening in the environment; has 
trouble with reading comprehension 4 
 
Severe:  Subject unable to follow 
conversation, remember what he's read, 
or follow TV plot 5 
 
Inattentiveness During Mental Status Testing 
The subject may perform poorly on simple tests 
of intellectual functioning in spite of adequate 
education and intellectual ability.  This should be 
assessed by having the subject spell "world" 
backwards and by serial 7's (at least a tenth 
grade education) or serial 3's (at least a sixth 
grade education) for a series of five subtractions.  
A perfect score is 10. 
No Errors 0 SS34
 
Questionable:  No errors but subject 
performs in a halting manner or 
makes/corrects an error 1 
 
Mild, But Definite (One Error) 2 
 
Moderate (Two Errors) 3 
 
Marked (Three Errors) 4 
 
Severe (More Than Three Errors) 5 
 
Global Rating of Attention 
This rating should assess the subject's overall 
ability to attend or concentrate, and include both 
clinical appearance and performance on tasks. 




Mild, But Definite Inattentiveness 2 
 
Moderate Inattentiveness 3 
 
Marked Inattentiveness 4 
 










Calgary Depression Scale for Schizophrenia 
Interviewer:   Ask the first question as written. Use follow up probes or qualifiers at your discretion. Time frame 
refers to last two weeks unless stipulated. N.B. The last item, #9, is based on observations of the entire interview. 
 
1. DEPRESSION: How would you describe your mood over the last two 
weeks? Do you keep reasonably cheerful or have you been very 
depressed or low spirited recently? In the last two weeks how often 
have you (own words) every day? All day? 
 
0. Absent 
1. Mild Expresses some sadness or discouragement on questioning. 
2. Moderate Distinct depressed mood persisting up to half the time over last 
2 weeks: present daily. 
3. Severe Markedly depressed mood persisting daily over half the time 
interfering with normal motor and social functioning. 
 
2. HOPELESSNESS: How do you see the future for yourself? Can you 
see any future? - or has life seemed quite hopeless? Have you given 
up or does there still seem some reason for trying? 
 
0. Absent 
1. Mild Has at times felt hopeless over the last two weeks but still has 
some degree of hope for the future. 
2. Moderate Persistent, moderate sense of hopelessness over last week. Can 
be persuaded to acknowledge possibility of things being better. 
3. Severe Persisting and distressing sense of hopelessness. 
 
3. SELF DEPRECIATION: What is your opinion of your self compared 
to other people? Do you feel better, not as good, or about the same 
as others? Do you feel inferior or even worthless? 
 
0. Absent 
1. Mild Some inferiority; not amounting to feeling of worthlessness. 
2. Moderate Subject feels worthless, but less than 50% of the time. 
3. Severe Subject feels worthless more than 50% of the time. May be 




4. GUILTY IDEAS OF REFERENCE: Do you have the feeling that you  
are being blamed for something or even wrongly accused? What  
about? (Do not include justifiable blame or accusation. Exclude  
delusions of guilt.) 
 
0. Absent 
1. Mild Subject feels blamed but not accused less than 50% of the time. 
2. Moderate Persisting sense of being blamed, and/or occasional sense of 
being accused. 
3. Severe Persistent sense of being accused. When challenged, 
acknowledges that it is not so. 
 
5. PATHOLOGICAL GUILT: Do you tend to blame yourself for little 
things you may have done in the past? Do you think that you deserve  
to be so concerned about this? 
 
0. Absent 
1. Mild Subject sometimes feels over guilty about some minor 
peccadillo, but less than 50% of time. 
2. Moderate Subject usually (over 50% of time) feels guilty about past 
actions the significance of which he exaggerates. 
3. Severe Subject usually feels s/he is to blame for everything that has 
gone wrong, even when not his/her fault. 
 
6. MORNING DEPRESSION: When you have felt depressed over the last  
2 weeks have you noticed the depression being worse at any  
particular time of day? 
 
0. Absent No depression. 
1. Mild Depression present but no diurnal variation. 
2. Moderate Depression spontaneously mentioned to be worse in a.m. 
3. Severe Depression markedly worse in a.m., with impaired functioning 




7. EARLY WAKENING: Do you wake earlier in the morning than is  
normal for you? How many times a week does this happen? 
 
0. Absent No early wakening. 
1. Mild Occasionally wakes (up to twice weekly) 1 hour or more before 
normal time to wake or alarm time. 
2. Moderate Often wakes early (up to 5 times weekly) 1 hour or more before 
normal time to wake or alarm. 
3. Severe Daily wakes 1 hour or more before normal time. 
 
 
8. SUICIDE: Have you felt that life wasn’t worth living? Did you ever  




1. Mild Frequent thoughts of being better off dead, or occasional 
thoughts of suicide. 
2. Moderate Deliberately considered suicide with a plan, but made no 
attempt. 
3. Severe Suicidal attempt apparently designed to end in death (i.e.: 
accidental discovery or inefficient means). 
 
9. OBSERVED DEPRESSION: Based on interviewer’s observations  
during the entire interview. The question “Do you feel like crying?”  
used at appropriate points in the interview, may elicit information  
useful to this observation. 
 
0. Absent 
1. Mild Subject appears sad and mournful even during parts of the 
interview, involving affectively neutral discussion. 
2. Moderate Subject appears sad and mournful throughout the interview, with 
gloomy monotonous voice and is tearful or close to tears at times. 
3. Severe Subject chokes on distressing topics, frequently sighs deeply 
and cries openly, or is persistently in a state of frozen misery if 






















Over the last two weeks, how often 













1 Feeling nervous, anxious or on 
edge 
0 1 2 3 
2 Not being able to stop or control 
worrying 
0 1 2 3 
3 Worrying too much about different 
things 
0 1 2 3 
4 Trouble relaxing 
 
0 1 2 3 
5 Being so restless that it is hard to 
sit still 
0 1 2 3 
6 Becoming easily annoyed or 
irritated 
0 1 2 3 
7 Feeling afraid as if something 
awful might happen 




























Future-Directed Thinking in First Episode Psychosis 
 
Tick if yes: 
1. I confirm that I have read and understand the information sheet 
(version 2, 4th May 2013) for the above named research study and 
have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected. 
 
3. I agree to my GP being notified of my participation in the study if 
appropriate. 
 
4. I would like my contact details to remain on record for up to one 
year after completion of the study so that I can be contacted about 
the results. 
 




Signed:_________________  Date:________ Name:_______________ 
(Volunteer) 
 
Signed:_________________  Date:________ Name:_______________ 
(Researcher) 
  
Doctorate in Clinical Psychology 













Thank you for participating in our research today.  The study aims to find out about the 
links between views about the future, hopelessness, and suicide in people with psychosis.  
We also aim to try to find out whether there is a link between views of the future and the 
‘negative’  symptoms of psychosis such as lack of energy, feeling less emotional and lack of 
motivation. 
If the things we have talked about bring up any concerning thoughts or feelings in the 
future, please use the following contacts to access organisations that can support you.  In 
an emergency call 999 or visit your local A&E department. 
x Contact your GP 
x NHS Direct 
For details of local crisis support services or advice on accessing local A&E 
www.nhsdirect.nhs.uk 
Tel: 111 (Mon-Sun, 24hrs) 
x The Samaritans 
An emotional support line 




Emotional support line for people in mental distress and their family, friends and 
carers. 
Tel: 0845 767 8000 (Mon-Sun, 6pm-11pm) 
It is also possible to email via an online form, and access online forums. 
www.sane.org.uk  
x Lifeline (Cambridge residents only) 
0808 808 2121, (Mon-Sun, 7pm-11pm) 
x Mind 
Mental Health Charity 
Infoline: 0300 123 3393 for information (Mon-Fri, 9am-6pm) 
Info@mind.org.uk 
www.mind.org.uk 
x Rethink Mental Illness 
Mental Health Charity 
Tel: 0300 5000 927 for practical advice and info (Mon-Fri, 10am-2pm, except Bank 
Holidays) 
www.rethink.org 
x Anxiety UK 
www.anxietyuk.org.uk 
Helpline: 08444 775 774 (Mon-Fri, 9.30am-5.30pm) 





Help in a crisis for existing patients of 
 
West London Mental Health NHS Trust 
x During office hours, contact your care coordinator or the member of staff you 
usually see. 
x Outside office hours, contact the service user and carer support line on 0300 1234 
244 (open Mon-Sun, 24hrs). 
 
Cambridgeshire and Peterborough NHS Foundation Trust 
x During office hours, contact your care coordinator or the member of staff you 
usually see. 
x Outside office hours, contact the out of hours telephone support service on 0800 
052 2252 (Mon-Fri from 5pm-10pm; Sat, Sun and bank holidays from 8am-10pm). 
 
South  West  London  and  St  George’s  Mental  Health NHS Trust 
x During office hours, contact your care co-ordinator or the member of staff you 
usually see. 
x Outside office hours, contact the Crisis Line on 0800 028 8000 (Mon-Fri 5pm-9am; 
Sat and Sun 24hrs).  
 
In an emergency call 999 or visit your local A&E department. 
 
 
 
 
 
 
